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Summary 
 
Trypanosoma brucei, the agent causing African trypanosomiasis or sleeping sickness, 
constitutes one of the best-studied biological models so far. In order to adapt to different 
environments, this parasite mainly regulates gene expression by post-transcriptional 
mechanisms such as mRNA stability and translation. These processes are mediated by the 
interaction of sequences located in the 3’-UTR with trans acting factors. 
 
RRM-proteins are involved in many aspects of the RNA metabolism. However, the function 
of most of them is unknown. The first part of this work deals with the characterisation of 
RBP3 and its role in developmental control of gene expression. Orthologues of this protein 
are found in T. cruzi, T. congolense and L. major.  Over-expression and depletion of TbRBP3 
by RNAi suggest a stage-specific role for this protein in bloodstream cells. Microarray studies 
comparing wild-type cells with cells where TbRBP3 levels have been perturbed (either by 
RNAi or over-expression) were unsuccessful in revealing putative mRNA targets, suggesting 
that this protein is not involved in control of mRNA levels.  Pull down of TbRBP3-RNP 
complexes allowed the identification of several transcripts that selectively bind this protein. 
Specifically, the interaction of cyclin F-box and ZFP-mRNAs was confirmed by RT-PCR and 
the role of the over-expression of TbRBP3 at mRNA levels was determined by Northern blot 
analysis. Unfortunately, attempts to identify TbRBP3 interaction partners have failed. Studies 
to determine the role of this protein are in progress. 
 
Specific sequences in the 3-UTR of stage-specific transcripts are involved in mRNA turnover 
and translation. In this work, several regulatory elements involved in the developmental 
regulation of the amino acid transporter 11 are reported. A region between nt 290-618 of this 
3’-UTR is required to down-regulate mRNA levels of the CAT reporter gene in bloodstream 
forms. Moreover, the presence of 2 elements involved in translational repression was also 
established. Several approaches used to identify interacting proteins of the AATP 11 3’-UTR 
under physiological conditions were unsuccessful. Approaches using in vitro conditions are 
suggested. 
 
 
 
 
  
Zusammenfassung 
 
Zusammenfassung  
 
 
Trypanosoma brucei, der afrikanische Trypanosomiasis oder Schlafkrankheit verursacht, ist 
einer der bisher am besten untersuchten biologischen Modellorganismen. Um sich an 
unterschiedliche Umgebungen anzupassen, reguliert dieser Parasit  die Genexpression post-
transkriptionell, hauptsächlich über mRNS Stabilität und Translation. Diese Prozesse werden 
durch die Interaktion zwischen Sequenzen, die  sich in der 3'-UTR befinden und Proteinen 
reguliert. 
 
Trotz ihrer Rolle in vielen Aspekten des RNS-Metabolismus ist die Funktion der meisten 
RRM-Proteine unbekannt. Der erste Teil dieser Arbeit beschäftigt sich mit der 
Charakterisierung von RBP3 und seiner Rolle in der post-transkriptionellen Kontrolle. 
Orthologue dieses Proteins findet man in T. cruzi, T. congolense und L. major. 
Überexpression und Hemmung von TbRBP3 mittels RNAi zeigen eine stadium-spezifische 
Rolle für dieses Protein in den Blutstromzellen an. Microarraystudien, die Wildtypzellen mit 
TbRBP3-RNAi oder –überexprimierenden Zellen vergleichen, führten nicht zur Identifikation 
einer Ziel-mRNS. Diese Ergebnisse weisen daraufhin, dass dieses Protein keine Funktion bei 
der Kontrolle von mRNS Mengen hat. Isolation der TbRBP3-RNP Komplexe  erlaubte die 
Identifizierung von verschiedenen mRNS, die selektiv dieses Protein binden. Insbesondere 
wurden die Interaktion der cyclin F-Box und ZFP-mRNS durch RT-PCR bestätigt und die 
Rolle der Überexpression von TbRBP3 auf mRNA Levels wurde durch Northernblotanalyse 
untersucht. Versuche, TbRBP3-Interaktionpartner in T. brucei zu finden, blieben erfolglos.  
Versuche, um die Rolle dieses Proteins festzustellen werden durchgeführt. 
 
Spezifische Sequenzen, die sich in der 3-UTR von stadiumspezifischen Genen befinden, sind  
an mRNS Stabilität und Translation beteiligt. In dieser Arbeit wurden regulierende Elemente 
identifiziert, die an der Entwicklungskontrolle des Aminosäuretransporters 11 beteiligt sind. 
Die Region zwischen nt 290-618 dieser 3'-UTR ist für die geringere Abundanz der mRNS 
eines CAT Reportergens in der Blutstromform verantwortlich. Außerdem wurden noch zwei 
Elemente gefunden, die in translationelle Repression verwickelt sind. Versuche, um AATP 
11-3’-UTR-Interaktionsproteine unter physiologischen Konditionen zu finden, waren 
erfolglos. Experimente unter in vitro Bedingungen werden vorgeschlagen. 
 
Introduction 
 
1  Introduction 
 
 
The kinetoplastids are a widespread group of flagellated protozoa. They are mainly known by 
their ability to parasitize virtually all animal groups as well as plants and insects. However, 
there are also free-living kinetoplastids which feed on bacteria in aquatic, marine and 
terrestrial environments. These parasites are named after one of their most unusual features, a 
mitochondrial DNA known as kinetoplast DNA (kDNA). The kinetoplast is unique in its 
structure, function, and mode of replication (Renger and Wolstenholme 1971; Simpson 1973; 
Shapiro and Englund 1995; Liu, Liu et al. 2005). 
The kinetoplastids are one of the best-studied examples of ancient eukaryotes. Phylogenetic 
studies based on data from rRNA (18S rRNA gene) and protein-coding genes established the 
monophyletic origin of this group (Stevens and Gibson 1999; Stevens, Noyes et al. 2001; 
Ginger 2005). In particular, three distinct species of this parasite have been studied intensively 
because they are the main agents for diseases of underprivileged people: Leishmania spp. 
(leishmaniasis), Trypanosoma cruzi (Chagas' disease) and Trypanosoma brucei complex 
(African sleeping sickness).   
Leishmaniasis is a group of visceral, muco-cutaneous and cutaneous diseases, caused by 
protozoa of the genus Leishmania. This parasite invades and multiplies inside the 
macrophagues of many vertebrates such as humans and dogs. The primary vectors for the 
transmission of Leishmania are female sandflies (Phlebotomus and Lutzomyia). There are 20 
species and subspecies of this parasite that infect humans. The disease is prevalent in 88 
countries and the 350 million people live at risk in endemic areas. The World Health 
Organization (WHO) estimates that 12–14 million people are affected and 1.5–2 million new 
cases occur per year.  Visceral leishmaniasis (VL or Kala azar) caused by L. donovani spp. is 
the most severe form of the disease and it is fatal if left untreated. There are 400.000–500.000 
of new cases every year mainly in South Asia (Bangladesh, India and Nepal). The most 
common form of leishmaniasis is the cutaneous form (CL) and it is due to infection with L. 
major. There are between 1’000.000 to 1’500.000 of people infected every year, most of them 
in Asia (Afghanistan, Iran and Saudi Arabia) and South America (Brazil and Peru). Other 
form of the disease is the mucocutaneous leishmaniasis (MCL) which is due to L. braziliensis 
and panamensis infection (www.who.int) (Alvar, Croft et al. 2006).  
Trypanosomiases are caused by parasites of the genus Trypanosoma affect people in Africa, 
Central and South America.  Chagas disease is found only in Latin America and is caused by 
T.  cruzi. 13 million people are currently estimated to be infected with this parasite. The 
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primary vector is the reduviid bug Triatoma infestans. About 25% of infected people show 
disease symptoms. Chronically infected patients eventually suffer from irreversible damage to 
the heart and digestive tract. This disease causes considerable morbility resulting in 
approximately 14,000 annual deaths. The control of Chagas disease in the last two decades 
has been a substantial public health achievement. The incidence of this disease was reduced 
by over 65% between 1990 and 2000, from an estimated 700,000 cases per year to fewer than 
200,000. This is mainly due to elimination of the insect vector in many countries in South 
America (www.who.int) (Yamagata and Nakagawa 2006). 
Human African trypanosomiasis (HAT) or sleeping sickness is caused by Trypanosoma 
brucei and transmitted by tsetse flies (Glossina spp.). The disease is fatal if not treated and 
affects individuals in over 30 sub-Saharian countries. Recent estimates indicate that over 60 
million people living in some 250 foci are at risk of contracting the disease, and there are 
about 300,000 new cases each year. However, less than 4 million people are under 
surveillance and only about 40,000 are diagnosed and treated, mainly due to the lack of 
resources to control the disease properly and to improve methods of diagnosis and 
chemotherapy (www.who.int) (Barrett 1999; Barrett 2006; Brun and Balmer 2006). 
Sleeping sickness occurs in two forms: a chronic one caused by T. b. gambiense, which 
occurs in west and central Africa; and an acute form, caused by T. b. rhodesiense, which 
occurs in eastern and southern Africa. T. b. brucei, a third subspecies of T. brucei causes 
Nagana in cattle but does not infect humans and is commonly used as a laboratory model 
organism. Uganda is the only country harbouring both forms of HAT. There are indications 
that this may change in the near future because areas with T. b. gambiense and T. b. 
rhodesiense are expanding (Brun and Balmer 2006). 
Early symptoms, which include fever, headache and enlarged lymph glands and spleen, are 
more severe and acute in T.b. rhodesiense infections. Advanced symptoms include 
neurological and endocrine disorders. As the parasites invade the central nervous system, 
mental deterioration begins, leading to coma and death (www.who.int).   
 
1.1 T. brucei life cycle 
As most of the protozoa parasites, Trypanosoma has to adapt to several environmental 
conditions (insect vector and mammal host), which requires morphological, biochemical and 
basic cell biological changes. Figure 1.1 shows the life cycle of T. brucei. The parasite is 
cyclically transmitted from mammal to mammal by the tsetse fly, Glossina spp ( ). In the 
bloodstream of mammalian hosts the parasite proliferates as morphologically slender form  
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( ) and survives free in the bloodstream by evading antibody responses through antigenic 
variation. This involves the sequential expression of antigenically distinct variable surface 
glycoproteins (VSGs). These proteins are linked to the outer membrane by a 
glycosylphosphatidylinositol (GPI) anchor (Young, Donelson et al. 1982; Hajduk 1984; 
McCulloch 2004; Pays, Vanhamme et al. 2004) ( ). As parasite number increase they 
differentiate into non-proliferative stumpy forms. These cells are arrested in G1 of the cell 
cycle and are preadapted for transmission to tsetse flies. Upon ingestion by the vector, 
bloodstream trypanosomes transform into the insect midgut form (procyclics) and switch the 
VSG coat to a coat composed of EP and GPEET procyclins ( , , ). This form contains a 
well developed mitochondrion that is required to generate energy.  After proliferation in the 
tsetse midgut, the parasite (epimastigotes) migrates to the salivary gland where after further 
divisions (  ) generates non-proliferative metacyclic forms which reacquire the VSG coat 
and are released into the salivary gland lumen, in preparation for inoculation into a new 
mammalian host ( ) (Matthews 2005). 
 
 
 
 
 
 
 
Fig. 1.1 Life cycle of Trypanosoma brucei (taken from Center for Diseases Control and Prevention, 
www.cdc.gov/ ) 
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1.2 Why is Trypanosoma special? 
The presence of a number of unusual characteristics such as antigenic variation, kinetoplast 
DNA, glycosomes, and trans splicing has focussed the attention of many people in this 
parasite. 
 
1.2.1 Genome organisation 
Trypanosoma genome contains 2 different DNAs: nuclear DNA and the mitochondrial DNA 
or kinetoplast. The haploid nuclear genome of the three main species of kinetoplastids (T. 
brucei, T. cruzi and L. major) was completely sequenced in 2005 (Berriman, Ghedin et al. 
2005; El-Sayed, Myler et al. 2005; Ivens, Peacock et al. 2005). The nuclear DNA of 
Trypanosoma brucei is about 35 Mb and is distributed among three size classes of 
chromosomes: most of the coding information is present in 11 pairs of megachromosomes 
(MC), which are numbered I to XI from smallest (1 Mb) to largest (> 6 Mb) and they contain 
9068 predicted genes. Other genome elements are the Intermediate chromosomes (200±900 
kb) and minichromosomes (50±150 kb), which usually contains repetitive elements such as 
the 177-bp repeat and silent VSG sequences (Ersfeld, Melville et al. 1999; El-Sayed, Hegde et 
al. 2000; Berriman, Ghedin et al. 2005)  
The mitochondrial DNA, known as the kinetoplast (kDNA) is composed of interlinked DNA 
rings (maxicircles and minicircles) and constitutes as much as 20% of the total DNA in the 
organism. Maxicircle gene products include rRNAs and subunits of respiratory complexes. 
However, these transcripts are cryptic and require editing to form a functional mRNA. RNA 
editing is the process by which mitochondrial transcripts are transformed into translatable 
mRNAs by the insertion and deletion of uridines. The specificity of this mechanism is 
controlled by minicircle-encoded guide RNAs that serve as templates for uridylate-insertion 
and deletion. (Benne, Van den Burg et al. 1986; Shapiro and Englund 1995; Stuart, Allen et 
al. 1997; El-Sayed, Hegde et al. 2000; Ginger 2005; Liu, Liu et al. 2005; Stuart, Schnaufer et 
al. 2005) 
 
1.2.2 Metabolism 
In the mammalian host, T. brucei relies upon glucose metabolism for energy generation. 
Uniquely, the first seven enzymes of the glycolytic pathway are compartmentalised within a 
specialized peroxisome, the glycosome (Opperdoes 1987). The mitochondrion of the 
bloodstream trypanosome plays no direct role in ATP production (apart from reoxidising 
glycerol-3-phosphate), and the end product of glycolysis is excreted from the cell. Therefore 
Introduction 
 11
this organelle is underdeveloped. On the other hand, procyclic trypanosomes rely on 
mitochondrial energy generation for their viability and their energy metabolism is 
characterised by the aerobic fermentation of carbohydrates (glucose) and amino acids mainly 
exogenous proline (Berriman, Ghedin et al. 2005; Ginger 2005). According to this, the 
presence of a family of 38 amino acid transporters has been reported in T. brucei (Berriman, 
Ghedin et al. 2005). 
 
1.2.3 Gene expression in Trypanosomatids 
 
1.2.3.1 Transcriptional control: 
One of the main features in Trypanosoma is that the genes are transcribed in large 
polycistronic precursor RNAs. Only few of the different ORFs contain introns and the coding 
sequences are separated by short intergenic regions.  This precursor is processed into mature 
monocistronic mRNAs through the excision of a coding region, capping upstream of the ATG 
start codon by trans-splicing, and polyadenylation. Trans-splicing is a reaction in which a 39-
nucleotide spliced leader sequence is added at an AG dinucleotide downstream of a 
polypyrimidine tract (Agabian 1990; Liang, Haritan et al. 2003). This mechanism is coupled 
to the addition of a poly (A) tail to the gene immediately upstream in the cluster. 
Polyadenylation usually occurs 200–500 nucleotides upstream of the spliced leader addition 
site (Gilinger and Bellofatto 2001; Martinez-Calvillo, Yan et al. 2003; Benz, Nilsson et al. 
2005). Only four examples of genes containing introns are evident in the trypanosomatid 
genomes, the poly (A) polymerase (PAP) genes of T. brucei and Trypanosoma cruzi (Mair, 
Shi et al. 2000), possibly one ATP-dependent DEAD/H RNA helicase and  two hypothetical 
RNA binding proteins and (Ivens, Peacock et al. 2005).  
Little is known about the mechanism of transcription initiation in trypanosomatids, and only a 
few promoters have been functionally analyzed. T. brucei RNA polymerase I (RNAP I) 
transcribes the pre-rRNA (18S, 5.8S and 28S) gene cluster, the mRNAs from the 
bloodstream-form variant surface glycoproteins (VSGs) and the procyclic-form procyclins 
(EPs and GPEETs). These promoters for these transcripts have been already characterised 
(Biebinger, Rettenmaier et al. 1996; Clayton 2002; Pays 2005). RNA polymerase III 
transcribes most U RNAs in addition to tRNAs (Palenchar and Bellofatto 2006). 
In T. brucei, the genes are bidirectionally distributed on the chromosome and oriented to both 
telomeres. RNA polymerase II (RNAP II) is responsible for the transcription of the majority 
of mRNAs, as well as the SL RNA gene (Gilinger and Bellofatto 2001). Although the SL 
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RNA promoter has been well-studied (Gilinger and Bellofatto 2001; Das and Bellofatto 
2003), RNA polymerase II promoters for protein coding genes have not been identified. 
Experimental evidence suggests that polycistronic transcription by RNA polymerase II 
(RNAP II) initiates bidirectionally in the region located between the two gene clusters. 
Transcription usually terminates in the region containing tRNA, rRNA, and/or snRNA genes 
(Andersson, Aslund et al. 1998; Martinez-Calvillo, Yan et al. 2003; Martinez-Calvillo, 
Nguyen et al. 2004). The T. brucei RNA pol II has been characterized (Das, Li et al. 2006) 
and the presence of few basal transcription factors found in other eukaryotes has been 
reported (Das, Zhang et al. 2005; Ivens, Peacock et al. 2005; Palenchar and Bellofatto 2006).  
Due to absence of regulation of transcription initiation by RNA polymerase II at the level of 
transcript initiation, gene expression is predominantly regulated through post-transcriptional 
mechanisms (Clayton 2002). 
 
1.2.3.2 Post-transcriptional regulation and role of the 3’-unstranslated region 
(3’-UTR): 
In order to adapt to the different environments provided by both the insect vector and the 
mammalian host, Trypanosoma relies on post-transcriptional mechanisms to control gene 
expression. This is achieved mainly through differential RNA processing, mRNA stability 
and translation These activities involve interactions between cis elements –mostly located in 
the 3’-UTR of the transcript and trans acting factors –RNA binding proteins. These regulatory 
sequences determine the mRNA abundance by modulating RNA degradation and often also 
translation efficiency (Clayton 2002).   
The role of the 3’UTR in control of mRNA stability and in particular, the presence of specific 
sequences which confers developmental regulation, has been elucidated by using 
chloramphenicol acetyl transferase (CAT) or luciferase reporter genes (Hehl and Roditi 1994; 
Berberof, Vanhamme et al. 1995; Furger, Schurch et al. 1997; Teixeira and daRocha 2003). 
These are some examples about the regulation mediated by 3’-UTRs in Trypanosoma: in T. 
cruzi, the abundance of Gp72, Gp85 and amastin mRNA is upregulated in amastigotes 
(Nozaki and Cross 1995). In particular, steady state levels of amastin mRNA are 60 fold 
higher and this upregulation is mediated by a region in the 3’-UTR that stabilizes the 
transcript (Teixeira, Kirchhoff et al. 1995; Coughlin, Teixeira et al. 2000; Teixeira and 
daRocha 2003). In mammalian cells AU-rich elements (ARE) present in the 3’-UTR are 
involved in destabilization of short life mRNAs such as interleukins and oncogenes (Chen and 
Shyu 1994; Chen, Xu et al. 1995). Similar destabilizing elements have been found in the 3’-
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UTR of SMUG-mucin transcripts. These sequences promote rapid degradation of mucin 
mRNA upon differentiation to metacyclic trypomastigotes. This is mediated by interactions 
with the RNA binding proteins TcUBP1 and TcUBP2 (D'Orso and Frasch 2001; D'Orso and 
Frasch 2001). The higher amount of tubulin mRNA in epimastigotes is also related with the 
presence of positive and negative elements in this region (Bartholomeu, Silva et al. 2002).  
In Leishmania donovani, the 3’-UTR is involved in the expression levels of A2 transcripts in 
amastigotes (Charest, Zhang et al. 1996). The accumulation of Hsp70 and Hsp83 transcripts 
upon heat shock is mediated by the 3’-UTR in L. infantum (Zilka, Garlapati et al. 2001; 
Quijada, Guerra-Giraldez et al. 2002; Folgueira, Quijada et al. 2005). A translational effect of 
these elements has also been observed (Quijada, Guerra-Giraldez et al. 2002; Folgueira, 
Quijada et al. 2005). The selective accumulation of the variant S of Gp63 in the stationary 
promastigote (the infective stage) also relies on specific sequences located in the untranslated 
region (Ramamoorthy, Swihart et al. 1995; Myung, Beetham et al. 2002). 
Regulatory 3’-UTR elements have been best characterized in T. brucei.  Berberof was the first 
to identify sequences in the 3'-UTR of the VSG mRNAs of T.brucei involved in expression in 
bloodstream forms (Berberof, Vanhamme et al. 1995).  Another transcript regulated by this 
mechanism is the fructose bisphophate aldolase mRNA, which is 6-fold more abundant in 
bloodstream trypomastigotes than in procyclic forms (Clayton 1985; Hug, Carruthers et al. 
1993; Hotz, Lorenz et al. 1995). Similarly, two hexose transporters (THTs) mRNAs are 
developmentally regulated by their 3’-UTRs. THT1 mRNA is expressed exclusively in the 
bloodstream and THT2 mRNA in the procyclic stage (Hotz, Lorenz et al. 1995). 
The presence of U-rich elements (UREs) in the 3-UTR of stage-specific mRNAs such as EP1 
procyclin, PGKB and PPDK has been reported (Quijada, Guerra-Giraldez et al. 2002). They 
are similar to AU-rich elements found in the 3’-UTRs of transiently expressed proto-
oncogenes, lymphokines and cytokines in mammalian cells (Chen and Shyu 1994; Chen, Xu 
et al. 1995). The role of these sequences in mRNA destabilization in bloodstream forms has 
been demonstrated using reporter genes under the control of these 3’-UTRs or the 
corresponding URE-deleted version (Hotz, Hartmann et al. 1997; Schurch, Furger et al. 1997; 
Quijada, Guerra-Giraldez et al. 2002). 
The genes for the cytosolic and glycosomal phosphoglycerate kinases (PGKs) of T. brucei are 
found in a compact tandem array together with a third PGK-related gene, PGKA, which is 
expressed at low level. Expression of the two PGK genes (PGKB and PGKC) is differentially 
regulated in the life cycle of T. brucei: the glycosomal PGK (PGKC) protein and its mRNA 
are abundant in the mammalian stage of the cycle but not in the insect stage, whereas the 
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reverse is observed for the cytosolic PGK (PGKB) protein and its mRNA (Gibson, Swinkels 
et al. 1988). The sequences responsible for this regulation are located in the 3’-UTR of the 
different transcripts (Blattner, Helfert et al. 1998; Quijada, Guerra-Giraldez et al. 2002; 
Colasante, Robles et al. 2007).  
The 3’-UTRs of the mRNA encoding the surface proteins EP and GPEET in T. brucei 
procyclic forms are the best characterized regulatory motifs in Trypanosoma. These proteins 
are undetectable in bloodstream forms, and the regulation occurs at several levels, mainly at 
mRNA abundance and translational levels.  The transcript is 11-fold more abundant in 
procyclic forms compared to bloodstreams and in this stage the translation is suppressed by 
10-fold relative to the insect forms (Furger, Schurch et al. 1997; Hotz, Hartmann et al. 1997).  
The presence of 2 specific sequences in the 3’-UTR are responsible for this control: a 16-mer 
stem-loop which functions as a stabilizing element in procyclic forms (Furger, Schurch et al. 
1997; Schurch, Furger et al. 1997) and a 26 U-rich element which is involved in decreasing 
the stability of the transcript and translation repression in bloodstream forms (Furger, Schurch 
et al. 1997; Hotz, Hartmann et al. 1997; Schurch, Furger et al. 1997). Secondary structure 
analysis showed that this 3’-UTR can be divided into three domains. Domains I and III that 
form stable structures, and a central domain (domain II) containing the 26-mer.  Studies using 
enzymatic digestion and lead hydrolysis showed that domain II is normally in single-stranded 
conformation (Drozdz and Clayton 1999).  
Other developmentally regulated genes that have been studied include GPI-PLC (Webb, 
Burns et al. 2005; Webb, Burns et al. 2005) (GPI-PLC mRNA steady state levels are higher in 
procyclic cells) and COX complex which is present in procyclics. COX V mRNA contains a 
U-rich element in the 3’-UTR which is involved in translational control, COX VI 3’-UTR also 
confers translational regulation and finally COX IX 3’-UTR is involved in controlling mRNA 
abundance (Mayho, Fenn et al. 2006). 
The mechanism of mRNA turnover in T. brucei has been established by mapping of 
degradation intermediates of reporter mRNAs bearing different 3’-UTR (Irmer and Clayton 
2001). T. brucei has at least two different mRNA degradation pathways. The first one is 
involved in degrading constitutive mRNAs (such as the mRNAs encoding actin or histone 
H4) and stable mRNAs (such as PGKC in bloodstream forms). It is not present in 
developmentally down-regulated. It involves deadenylation and decapping, followed by 
bidirectional degradation mediated by both 5’ to 3’ exonucleases (XRNA) and 3 to 5’ 
exonucleases (exosome) ( Irmer and Clayton 2001; Haile, Estevez et al. 2003; Li, Irmer et al. 
2006). 
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The second pathway deals with developmentally downregulated mRNAs that need to be 
rapidly destroyed (such as the mRNAs encoding EP procyclin  through the 26-mer element) 
and it  involves bidirectional degradation mediated by both 5’ to 3’ exonucleases  (XRNA) 
and 3 to 5’ exonucleases (exosome) (Irmer and Clayton 2001; Haile, Estevez et al. 2003; Li, 
Irmer et al. 2006). This mechanism is delayed after down-regulation of either XRNA (Li, 
Irmer et al. 2006) or the exosome (Haile, Estevez et al. 2003). This pathway affects 70% of 
the mRNA and does not require deadenylation (Irmer and Clayton 2001). The remaining 30% 
of the RNA is apparently subjected to the default pathway initiated by deadenylation (Li, 
Irmer et al. 2006).  
 
1.3. RNA binding proteins 
RNA binding proteins can be grouped into families based on a common sequence motif that 
interacts directly with RNA (Mattaj 1993; Chen and Varani 2005). In many proteins from 
bacteria and viruses, RNA recognition is mediated by small highly basic stretches rich in Arg 
and Lys residues. Two examples are the regulators of gene expression in HIV viruses Tat and 
Rev (Weeks, Ampe et al. 1990; Heaphy, Finch et al. 1991). In eukaryotes, many proteins 
involved in RNAi and micro-RNA processing pathway contain the Piwi Argonaut and Zwille 
(PAZ) domain (Lingel, Simon et al. 2003; Lingel, Simon et al. 2004). Although it is mainly 
found in DNA-binding proteins, the zinc-finger motif (CCHH-type) also binds to RNA and 
participates in protein–protein interactions. The tandem zinc finger domain (TZF) of the 
protein TIS11d binds to an AU-rich element in the 3’-UTR of the TNF mRNA to promote 
its deadenylation and degradation (Hudson, Martinez-Yamout et al. 2004). HnRNP proteins 
and many nucleolar proteins such as nucleolin are characterized by the presence of RGG 
(Arg-Gly-Gly) boxes (Ghisolfi, Joseph et al. 1992; Kiledjian and Dreyfuss 1992). The 
generation of the small nuclear ribonucleoprotein particles (snRNPs) involved in pre-mRNA 
splicing requires the association of the seven Sm proteins in a heteromeric core that is able to 
bind snRNAs (Kambach, Walke et al. 1999; Wang, Palfi et al. 2006). RNA modifying 
enzymes also interact with RNA through their catalytic domain.  RNAse III proteins such as 
Drosha and Dicer, involved in processing RNAi and micro-RNA precursors belong to this 
category (Chen and Varani 2005). Proteins containing PUF repeats (a 40 amino acids motif) 
(Zamore, Williamson et al. 1997) bind the 3’-UTR of hunchback mRNA in Drosophila 
(Wickens, Bernstein et al. 2002) and the 3’UTR of fem-3 mRNA in C. elegans, leading to an 
increase in the rate of deadenylation and/or repression of translation of these mRNAs (Zhang, 
Gallegos et al. 1997). In eukaryotes, the three most common  RNA binding motifs are the 
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RNA recognition motif (RRM), the double stranded RNA-binding domain (dsRBD) and the 
K-homology (KH) domain. RRM and KH proteins interact primarily with single-stranded 
RNA, while the dsRBD binds to structured RNA and is involved in dsRNA metabolism 
(Staufen protein) (Chen and Varani 2005). 
The RNA recognition motif (RRM), also known as RNA-binding domain (RBD) or 
ribonucleoprotein domain (RNP) is found in all life kingdoms. In eukaryotes, this motif is one 
of the most abundant protein domains. It consists of 90 amino acids containing a central 
sequence of eight conserved residues that are mainly aromatic and positively charged (Lys ⁄ 
Arg- Gly-Phe ⁄ Tyr-Gly ⁄ Ala-Phe ⁄ Tyr-Val ⁄ Ile ⁄ Leu-X-Phe ⁄ Tyr, where X can be any amino 
acid) called RNP-1. Sometimes, a second conserved motif of 6 amino acids is also present 
(RNP-2) (Kenan, Query et al. 1991). According to the Pfam protein families database, a total 
of 6768 RRM motifs have been identified in 3541 different proteins 
(http://www.sanger.ac.uk/cgi-bin/Pfam/getacc?PF00076). They are often found as multiple 
copies within a protein (44% of eukaryotic RRM proteins contain two to six RRMs) and ⁄ or 
together with other domains (21% of eukaryotic RRM proteins) as the zinc fingers of the 
CCCH and CCHC type (21% of those with an additional domain), the polyadenylate binding 
protein C-terminal domain (PABP or PABC, 10%), and the WW domain (9 %) (Chen and 
Varani 2005; Maris, Dominguez et al. 2005). 
In Trypanosoma, most of the RNA binding proteins characterised so far are involved in 
editing, rRNA processing and splicing. BLAST analysis predicts 75 RRM-type proteins in T. 
brucei genome, 80 in Leishmania and 135 in T. brucei (De Gaudenzi, Frasch et al. 2005). 
Many of them are associated with other motifs as zinc fingers and RGG domains.  
NRBD1 and NRBD2 (previously p34 and p37), two RRM-type proteins are involved in the 
import and/or assembly pathway of 5S rRNA during ribosome biogenesis in T. brucei (Pitula, 
Ruyechan et al. 2002, Zhang, 1997 #130). They interact with NOPP44/46, the first RGG-type 
protein characterized that has affinity for poly (U) sequences in the nucleolus (Das, Peterson 
et al. 1996; Pitula, Ruyechan et al. 2002). RBP11 has domains suggestive of involvement in 
rRNA processing or transcription (De Gaudenzi, Frasch et al. 2005). Many RNA binding 
proteins are involved in editing.  The guide RNA binding protein gBP21 that promotes the 
annealing of gRNAs to the pre-edited mRNA has been identified in T. brucei, L.tarentolae 
and C. fasciculata (Koller, Muller et al. 1997; Allen, Heidmann et al. 1998; Muller, Lambert 
et al. 2001; Muller and Goringer 2002; Brecht, Niemann et al. 2005; Vondruskova, van den 
Burg et al. 2005). TbMP42, a zinc finger protein that binds dsRNA, is involved in the editing 
reaction cycle through its exo- and endoribonuclease activity (Brecht, Niemann et al. 2005). 
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RBP16 interacts with gRNA through a cold shock domain (CSD) and a RRG domain. 
Depletion of this protein selectively affects the editing of apocytochrome B (CYb) and also 
has a role in maintaining mRNA stability of several non edited mRNAs (Hayman and Read 
1999; Pelletier, Miller et al. 2000; Pelletier, Xu et al. 2001). Other RNA binding proteins 
involved in this process are:  the oligo (U) binding protein TbRRG1 (Vanhamme, Perez-
Morga et al. 1998) and the RNA editing associated protein 1 (TbEAP1) (Madison-Antenucci 
and Hajduk 2001).  Both serine/arginine (SR)-rich proteins, TSR1 and TSR1IP have been 
implicated in the recognition of the 5’ and 3’ splicing sites in T. brucei (Ismaili, Perez-Morga 
et al. 1999; Ismaili, Perez-Morga et al. 2000). Homologues have been identified in T. cruzi 
(TcSR1) (Portal, Lobo et al. 2003). The U2 snRNP auxiliary factor 35 (U2AF35) has already 
been characterized in T. cruzi, T. brucei and L. major (Xu, Wen et al. 2001; Vazquez, 
Atorrasagasti et al. 2003). 
The Poly (A)-binding protein (PABP1), a RRM-type protein, was characterized in T. cruzi, T. 
brucei and Leishmania spp. Its role in translational control and mRNA turnover by interaction 
with the poly (A)-tail at the 3’-end of all mRNAs has been established (Batista, Teixeira et al. 
1994; Hotchkiss, Nerantzakis et al. 1999; Bates, Knuepfer et al. 2000). 
RNA binding proteins are also involved in the 3’ to 5’ mRNA degradation pathway: TbRRP4, 
TbRRP40, and TbCSL4 all have S1 RNA-binding activity and are part of the exosome 
complex (Estevez, Kempf et al. 2001). TbZFP1 and TbZFP2 are involved in differentiation of 
T. brucei (Hendriks, Robinson et al. 2001; Hendriks and Matthews 2005). The presence of 10 
PUF protein family members in T. brucei has been reported and their role in post-
transcriptional control is being investigated (Luu, Brems et al. 2006). 
Although several cis elements involved in RNA degradation have been found in 
Trypanosoma, just few interacting proteins have been identified. Only two proteins have been 
characterized so far: TcUBP-1 and TcUBP-2 (U-rich binding protein) control stabilization of 
small mucin mRNAs in T. cruzi through interactions with the 3’-UTR (D'Orso and Frasch 
2001; D'Orso and Frasch 2002; De Gaudenzi, D'Orso et al. 2003). Their T. brucei 
homologues TbUBP1 and TbUBP2 are also implicated in post-transcriptional gene regulation 
in T. brucei (C. Hartmann, unpublished data). 
 
1.4 Amino acid transporters 
While the metabolism of Trypanosoma bloodstream forms relies exclusively on glucose. 
Although proline is the main energy source in insect forms, other amino acids are also 
needed: glutamine is required for several biosynthetic pathways, cysteine as an additional 
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sulfur source, and tyrosine for protein synthesis. So far, three specific amino acid transporters 
systems, one for proline, one for arginine and one for aspartate were described in T. cruzi 
(Canepa, Silber et al. 2004; Geraldo, Silber et al. 2005; Silber, Rojas et al. 2006). A family of 
wide-spectra  amino acid transporters composed of  29 genes  in L. major, 38 in T. brucei, and 
42 in T. cruzi  is also present (Opperdoes 1987; Berriman, Ghedin et al. 2005).  
This family belongs to the eukaryotic-specific amino acid/auxin permease (AAAP) family 
(TC #2.18) and it is one of the most divergent families of transporters found in eukaryotes due 
to its extensive divergence at protein sequence (Young, Jack et al. 1999). One of the main 
features of these proteins is the presence of 11 transmembrane domains and the broad 
substrate specificity of some of its members. Many of them are able to transport all 20 natural 
amino acids found in proteins while other members apparently exhibit absolute specificity for 
a single amino acid (Young, Jack et al. 1999).  8 classes of these amino acid transporters are 
expressed in Leishmania donovani promastigotes (Akerman, Shaked-Mishan et al. 2004) and 
12 of them are reported in T. cruzi (Akerman, Shaked-Mishan et al. 2004; Bouvier, Silber et 
al. 2004).  One developmentally regulated amino acid transporter was characterized in L. 
amazonensis; it has homology to PAT6 in T. cruzi, and amino acid transporter 11 in T. brucei 
(Geraldo, Silber et al. 2005). Despite their presence in African trypanosomes, none of them 
has been studied so far. 
 
1.5 Aims of the work described in this thesis 
 
This thesis is the result of three different projects. Considering the role of some RRM-type 
proteins in post-transcriptional control, acting as regulators of developmentally expressed 
genes in T. cruzi and in T. brucei, the aim of the first work was the characterisation of 
TbRBP3, trying to establish its role in gene expression control. For this, microarray analysis 
was used. The other 2 parts of this manuscript rely on the cis elements present in the 3’-UTR 
of the mature mRNA that are involved in mRNA stability and translation. The identification 
of the sequences involved in the differential expression of the amino acid transporter 11 – a 
protein upregulated in the insect stages of this parasite-, was assessed by using a reporter gene 
and deletion mutants. Several strategies were employed to identify the proteins involved in 
this regulation. Finally, I tried to determine the role of T7 promoter on the toxicity of a 
reporter construct containing the chloramphenicol acetyl transferase gene under the control of 
PGKC 3’-UTR in bloodstream forms.  
Materials and methods 
 
2  Materials and methods 
2.1 Trypanosoma cell culture 
2.1.1 Determination of cell density  
The T. brucei culture was briefly homogenised by shaking the culture flask. 10μL was placed 
under a cover slip on a Neubauer improved counting chamber (Migge). The cells from two 
crossing 16-square-fields were counted, and their average was multiplied by 1 x 104, which 
gave the amount of cells in 1mL of the culture. Dilutions were made to maintain the cultures 
below 7 x 106 and 1-2 x 107/mL for bloodstream and procyclics respectively. 
 
 
 
 
 
 
2.1.2 Bloodstream-form (BS) trypanosome culture  
Bloodstream-form trypanosomes were kept in an incubator (Heraeus Instruments) at 37°C, 
5% CO2, in a humified atmosphere. The bottle caps were loosely tied to allowed gaseous 
exchange. Cells were harvested at densities up to 2,5 x 106 cells/mL* in supplemented HMI-9 
medium. All culture work was done under sterile conditions in a laminar flow hood. For 
cryopreservation, aliquots of culture in log phase of growth (1-2 x 106 cells/aliquot) were 
resuspended in 1 mL1 of HMI-9 with 10% glycerol in cryovials. The vials were wrapped in a 
thick layer of soft tissue paper and stored overnight at –80°C. This treatment allowed gradual 
freezing after which the tubes were transferred to cryoboxes in a liquid nitrogen tank. To 
restart cultures the cells were thawed at room temperature (RT) and transferred to 3 mL HMI-
9 medium. 
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HMI-9 medium 
IMDM (Gibco)             17.66g/L 
NaHCO3 (Roth)                          36mM 
Hypoxanthine (Serva)              1mM  
Na-pyruvate (Serva)                          1mM  
Thymidine (Sigma)                          160mM 
Bathocupronsulphonate (Serva)            50 mM 
 
Supplemented HMI-9 medium, 500mL 
HMI-9 supplemented with: 
Heat-inactivated FCS 10% (v/v) 
Penicillin/Streptomycin   50U/L (5mL of Penicillin-Streptomycin mix, Sigma) 
L-Cysteine-HCL.H2O   1.5mM (5mL of stock solution)  
-mercaptoethanol (Sigma)             0.14% (7.2μL in 5mL, filtered, added fresh) 
 
 Iscove’s Modified Dulbecco’s Medium, no supplements  
 FCS was heat-inactivated by incubating it at 56ºC for 30min. 
 * Bloodstream trypanosomes grow at low densities compared to procyclic trypanosomes, but 
easily die if the culture is overgrown and usually take long to restart growing. 
 
 
2.1.3 Stable transfection of bloodstream form trypanosomes 
All centrifugation steps were done at 2,000 rpm for 10min at RT (Heraeus). 1 x 107 cells from 
a log phase culture (1-2 x 106 cells/mL) were pelleted, resuspended in 5 mL of Cytomix and 
centrifuged again.  The pellet was resuspended in 0.5mL of Cytomix and transferred to a BTX 
cuvette at RT. About 10g of sterile linearised plasmid DNA were added and mixed by 
pipeting up and down and subjected to a single electric pulse on a BTX electroporator set for 
peak discharge at 1.6kV, and resistance timing mode R2 (24 Ohm). The cells were then 
transferred to 25mL of warm (supplemented) HMI-9, distributed in 24-wells microtiter plates 
(0.5mL/well) and incubated overnight at 37ºC. The next day, 0.5mL of medium with the 
appropriate antibiotics (depending on the background of the cells and twice the concentration 
of the selection antibiotic) was added to each well. Stable clones were established between 5-
7 days with adequate cell densities. The new clones were scaled up to 5mL of supplemented 
HMI-9 for further culture and downstream analysis. 
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Cytomix 
EGTA                2mM  
KCl                 120mM  
CaCl2                 0.15mM 
K2HPO4/KH2PO4                   10 mM (pH 7.6) 
HEPES                25 mM  
MgCl2                5 mM 
Glucose               0.5% (w/v) 
BSA                 100g/mL 
Hypoxanthine (Serva)   1mM  
pH 7.6 (with NaOH) 
The medium was filter sterilized and stored at 4°C 
2.1.4 Procyclic form trypanosome culture 
Procyclic form trypanosomes were cultured in tightly closed flasks in a 30oC-room at 
densities between 0.1-10 x 106 cells/mL* in supplemented MEM-Pros. All work was done 
under sterile conditions in a laminar flow hood. Cryopreservation and thawing was done as 
for bloodstream form but in supplemented MEM-Pros medium with 10% glycerol and at 
about 2 x 106 cells/aliquot.  
 
MEM-Pros       
CaCl2    265mg/L  NaH2PO4  0.14 g/L  
KCl    0.4g/L   HEPES  7.14g/L 
MgSO4.7H2O   0.2g/L   L-Arg-HCl  126mg/mL 
NaC1    6.8g/L   LCys-Cys  24mg/L 
L-His-HCl.H2O  42mg/L  L-Gln   292mg/L 
L-Ile   52mg/mL  L-Tyr    100mg/L 
L-Leu    52mg/L  L-Val    46mg/L  
L-Lys    73mg/L  L-Pro    600mg/L  
L-Met    15mg/L            Adenosine   12mg/L  
L-Phe    100mg/L            Ornithine-HCl  10mg/L  
L-Thr    48mg/L   pH: 7.4 
L-Try    10mg/L 
 
10mL of MEM non-essential amino acids (Gibco), 10mL of MEM Vitamins (Sigma) and 
10mg of Phenol Red were added to 1L of medium and the pH adjusted. The medium was 
filter sterilised, aliquoted at 450mL and kept at 4ºC. 
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Supplemented MEM-Pros medium, 500mL 
MEM-Pros with: 
Heat-inactivated FCS (Gibco)    10% (v/v) 
Hemin        7.5 mg/L (1.5mL of stock solution) 
Penicillin/Streptomycin      50U/L (5mL of Penicillin-Streptomycin (5000U/ml), Sigma) 
 
Hemin stock: 0.25% in 0.1M NaOH, autoclaved and stored at 4ºC. *Cultures of procyclic 
trypanosomes under 1 x 10
5
 cells/mL do not grow unless in conditioned medium, which is 
obtained after centrifugation and sterile filtration of a well-established culture of procyclic 
cells. It contains undetermined factors that enable growth of low-density cultures. 
 
2.1.5 Stable transfection of procyclic trypanosomes 
All centrifugation steps were done at 2,000 rpm for 10 min at RT (Heraeus). 
Cells were grown to log phase of culture (2-4 x 106cells/mL). 2 x 107 cells were washed once 
in 10mL of ice cold ZPFM (Zimmerman post-fusion medium). The pellet was resuspended in 
0.5mL of ice-cold ZPFM and transferred to a cold lmL cuvette (BTX) on ice. 10g of sterile 
linearized plasmid DNA was added and mixed by pipeting up and down. The cells were 
electroporated as described for bloodstream forms (Section 2.1.4.). The cells were then 
transferred to 10mL MEM-Pros with appropriate antibiotics according to cell background and 
incubated overnight at 30ºC. The following day, selection antibiotic was added to this culture 
and 1.5mL distributed to each well on the top row of a 24-well microtiter plate. 500μL of 
conditioned medium (i.e., medium obtained from a previous culture, centrifuged and sterile-
filtered) with appropriate antibiotics, was aliquoted into each of the remaining wells. The cells 
were distributed vertically following the principle of limiting dilution: 0.5mL of the culture in 
the first well on the first row was transferred to the second well. The dilution was done 
consecutively for the third and fourth well, always with cells from the immediate-upper well. 
Stable clones were established between 7-14 days with adequate cell densities. The cultures 
were often scaled up in volume (e.g. 5mL) for further culture and downstream analysis. 
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5X ZPFM 
NaCl  123mM 
KCI  8mM  
Na2HPO4 8mM  
KH2PO4  1.5mM  
MgAc   1.5mM  
Ca(OAc)2  90M  
pH: 7.0 (with NaOH or acetic acid) 
 
The medium was filter-sterilized and stored at 4ºC. 
 
2.1.6 Antibiotics used for selection of recombinant trypanosomes 
• Phleomycin (Cayla): Stock solution: 5mg/mL, stored at 4oC. 
Concentrations used in culture: 0.2g/mL (bloodstream); 0.5μg/mL (procyclics). 
• Hygromycin B (Life technologies): Stock solution: 50mg/mL, stored at 4ºC. 
Concentrations used in culture: 15g/mL (bloodstream); 50g/mL (procyclics).  
• Neomycin (G418, Gibco). Stock solution: 50mg/mL, stored at 4ºC. 
Concentrations used in culture: 0.5μg/mL (bloodstream); 12μg/mL (procyclics);  
• Blastidicin (Invitrogen). Stock solution: 5mg/mL, stored at –20oC. 
Concentration used in culture: 10g/mL (procyclics); 5g/mL (blood stream). 
• Puromycin (Sigma). Stock solution 1mg/mL, stored at 4oC. 
Concentration used in culture: 0.2ug/mL (bloodstream); 1 g/mL (procyclics) 
2.1.7 Tetracycline-inducible cells 
The 427-449 and 427-1313-cell lines (both bloodstreams and procyclics) have integrated the 
Tn10 tet repressor gene and express it constitutively. These cells can be transfected with 
inducible trypanosome expression vectors i.e., constructs containing a promoter with two 
operator sites where repressor molecules bind hence preventing promoter driven transcription. 
When Tetracycline (Tet) is added to the culture medium, it binds the repressor molecules, 
which then fall off the operator. This allows transcription of a given gene under the control of 
the (inducible) promoter. Tet-inducible vectors used in this work were pHD676 (with the 
PARP RNA pol l promoter), pHD918, p2T7-177-Hyg and p2T7TABlue (with the 
bacteriophage T7 promoters), pHD1484, pHD1485. 
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2.2 Basic methods for nucleic acids and proteins analysis 
2.2.1 Phenol extraction 
One volume (vol) of a 1:1 mix of Roti®-Phenol (Roth, equilibrated in TE buffer) and 
chloroform was added to DNA or RNA solution in TE or water respectively. The samples 
were gently mixed by inversion and centrifuged for 5 min at 13,000 rpm at RT. The aqueous 
phase was then ethanol precipitated. 
TE buffer 
Tris-HCI   10mM  (pH 7.5) 
EDTA   1mM 
2.2.2 Ethanol precipitation and washes 
To a DNA or RNA sample, 10% of its volume of 3M NaAc (pH 5.2) and 2.5 volumes of 
100% ethanol were added. After 30 min at -20ºC, the samples were centrifuged at 13,000 rpm 
for 15 min at 4ºC. The pellet was washed with 70% ethanol and air-dried. The pellet was then 
resuspended (TE/water) and incubated at 55ºC for 10 min to fully dissolve the sample. 
Samples were then stored in NaAc/ethanol mix at -20ºC (DNA) or at -80ºC (RNA). The 
samples were centrifuged and washed just before use. 
2.2.3 TCA precipitation 
If needed, proteins in aqueous samples were concentrated adding TCA at a final concentration 
of 105 and DOC (deoxyholic acid) at a final concentration of 0.15%. Then, the sample was 
mixed and incubated overnight on ice. The sample was vortexed briefly and centrifuged at 
13,000 rpm for 15 min at RT. The pellet was washed with 3 volumes of original sample 
volume of ice-cold acetone, incubated at RT for 10 min, then centrifuged at 13,000 rpm for 15 
min. The pellet was air-dried at room temperature for 10 min and stored at –20oC or dissolved 
in 1 X Laemmli buffer (Section 2.8.4), denatured for SDS–PAGE (Section 2.8.3).  
 
100% TCA     100% TCA + DOC 
TCA 100g in 41mL H2O   100% TCA  10mL  
DOC   40mg  
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2.3 Recombinant DNA technology 
2.3.1 PCR  
100ng of plasmid or genomic DNA were used as template in a 50 L-PCR reaction. The 
reaction mix included 1X PCR-buffer, 0.2 mM dNTPs, 1pmol each reverse and forward 
primers and 0.5 U of Taq-DNA pol (Amersham). A reaction volume of 25L was used for 
colony PCR (Section 2.4.3.3.). The tubes were placed in a thermocycler 
(RoboCycler®Gradient 96, Stratagene); the standard PCR steps were: DNA denaturation at 
94ºC for 1-5 min, 20-30 cycles of denaturation, primer annealing and elongation, and 10 min 
of elongation at 72ºC. The annealing temperature depended on the primer pairs used.  
The PCR reaction was analyzed by running 5 L in an ethidium-bromide-stained agarose gel. 
If there were a single PCR product, the PCR product was then purified using a QIAquick PCR 
purification Kit (Qiagen Inc.). If there were more than one product, the whole sample was 
electrophoresed and the specific product (determined by size) purified from the agarose gel 
(NucleoSpin Extract, Macherey Nagel). For cloning purposes, the primers were often 
designed with restriction endonuclease sites. These enabled the ligation of the product into a 
vector DNA cut with the same restriction enzymes that generate compatible ends (sticky end-
ligation). 
10X Taq-DNA pol buffer 
Tris-HCl   100 mM  (pH 9.0) 
KCl                             500mM 
MgCl2   15mM  
Triton X-100   1% (v/v) 
 
dNTPs 
2L of each of 100mM dATP, dGTP, dTTP and dCTP were added to an eppendorf tube and 
the volume made up to 100μL with sterile water.  This resulted in a final concentration of 
200μM for each dNTP. 5μL of this solution was used in a 50μL PCR reaction.    
Forward and reverse primers 
1μL of each primer (100pmol/μL) was used in a 50μL PCR reaction 
2.3.2 Restriction endonuclease digests 
Each enzyme was used in conditions recommended by the manufacturer - Amersham or New 
England BioLabs. Usually, 2-3U of enzyme were used to digest 1μg of DNA, taking care that 
the enzyme (usually stored in glycerol-containing buffers) constituted less than 10% of the 
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total reaction volume. Restriction enzyme digests were incubated for 2 h, at the optimum 
temperature. In case of digestion at DNA-ends (like PCR products), the reactions were 
incubated overnight. Cleavage of DNA substrate with two restriction endonucleases 
simultaneously (double digestion) was done in the buffer that resulted in the maximal activity 
for both enzymes. If no one buffer met the buffer requirements of both enzymes, the reactions 
were performed sequencially. First, cleavage was done with the restriction endonuclease that 
requires the lower salt reaction conditions, then salt concentration was adjusted (using a small 
volume of a high concentration salt solution) to approximate the reaction conditions of the 
second restriction endonuclease. The second enzyme was added and incubated to complete 
the second reaction. 
2.3.3 Creation of blunt ends in DNA fragments 
Following restriction enzyme digestion that generated 5’- or 3’-protruding ends, the desired 
fragment was gel purified (section 2.3.6.) and the overhangs filled-in as described below: 
2.3.3.1 Removal of 3’-overhangs  
About 3-5g of digested DNA was incubated (30 sec, 37oC) with 1μL of T4-DNA 
polymerase (Amersham, 4U/L), 1X DNA polymerase buffer and 1μL of dNTPs in a 20 L-
reaction was added for further 5min of incubation. The reaction was stopped by heat 
inactivation (75ºC for 10min). 
2.3.3.2 Fill-in of 5’-overhangs 
Approximately 3-5μg of DNA was incubated (15min at RT) with 1μL of the Klenow 
fragment of DNA Polymerase (USB, 5U/μL), 2μL of 10X buffer L (Amersham) and 1μL of 
dNTPs in a 20μl reaction volume. The enzyme was heat-inactivated (75ºC for 10min). 
 
dNTPs 
dATP, dGTP, dTTP and dCTP  2mM (final concentration of each) 
 
10X Buffer L (Amersham)  
Tris-HCI   100mM (pH 7.5) 
MgCl2     100mM 
DTT     10mM 
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2.3.4 Dephosphorylation of 5’-ends 
The removal of a phosphate group from a linearised plasmid with Calf Intestinal Phosphates 
(CIP, Boehringer Mannheim, 1 U/μL) prevents it from self-ligation and lowers background. 
About 2 μL of CIP were added to the restriction digest and incubated at 37ºC for 15 min.  The 
tube was transferred to 55ºC for 15 min. The reaction was stopped by addition of 2μL of 
500mM EDTA and heat inactivation (75ºC for 10 min). The DNA was purified by using the 
Qiagen Miniprep kit, or by gel extraction.  
2.3.5 Agarose gel electrophoresis 
Gels were prepared by melting 0.8-1.8 g agarose (Gibco) in 100mL of TAE buffer in a 
microwave oven. Ethidium bromide (approximately 30 g, from a stock solution at 
10mg/mL) was added for UV visualization. DNA molecules fractionated on 1 X TAE buffer 
for 30-90 min at 100-120V, and were then visualized and photographed under UV light. 
TAE buffer 
Tris-HCl   40mM 
EDTA   1mM (pH 8.0) 
Acetic acid   0.11% 
2.3.6 Purification of DNA fragments from agarose gels 
All steps were at RT. The purifications were done using a NucleoSpin® Extract kit 
(Macherey Nagel) following the manufacturer’s instructions. 
2.3.7 Ligation of DNA fragments 
DNA inserts excised from plasmid or PCR-generated were cloned into a vector prepared as 
described in sections 2.3.2 to 2.3.6. DNA fragments were ligated using 1U of T4-DNA ligase, 
with molar vector:insert DNA ratios of about 1:3. 1 μL each of 10X ligation buffer and T4-
DNA-ligase were added and the volume made upto 10μL with Nuclease–Free water. The 
ligation reactions were incubated at 16ºC overnight. 
10X Ligation buffer 
Tris-HCl   0.5M (pH 7.6) 
MgC12   0.1M 
ATP    10mM 
DTT    10mM 
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2.4 Amplification of recombinant DNA in bacteria 
2.4.1 Preparation of competent cells 
All centrifugation steps were carried out at 4ºC. 
Escherichia coli DH5 cells were taken from a frozen stock at -80ºC and incubated overnight 
at 37ºC on an antibiotic-free LB-agar plate. A single colony was picked and used to inoculate 
5mL of B medium. The culture was incubated at 37°C with vigorous shaking for about 2 h 
(OD550 ~ 0.3). The cells were then transferred to 100mL of medium pre-warmed to 37
oC and 
incubated for another 2 h (OD550 ~ 0.48). The culture was transferred into a Corex tube, 
incubated on ice for 5 min, and then centrifuged at 6,000 rpm for 5 min (Sorvall, SS34 rotor). 
The bacterial pellet was re-suspended in 40mL of cold TfbI buffer, incubated on ice for 5 min 
and centrifuged again at 6,000rpm for 5min. The pellet was re-suspended in 4mL of cold 
buffer TfbII, incubated on ice for 20min then aliquoted 200μL/tube for storage at –80oC.  
 
DH5 Cells (Promega) 
Genotype: supE44, lacU169(80lacZM15), hsdR17, gyrA96, thi-1, relAl 
 
B medium 
Trytone peptone (Difco)             20 g/L 
Yeast extract (Difco)              5 g/L 
MgS04 (20mM)                        5 g/L 
pH 7.6 (with KOH) 
The medium was autoclaved and stored at RT 
For agar plates: BactoTM AGAR (Difco)     15 g/L  
 
TfbI buffer      TfbII buffer 
KAc   30mM     MOPS   10mM 
RbCl2  100mM    CaCl2   75mM
 
CaCl2   10mM     RbCl2   10mM 
MnCl2  50mM     Glycerol  15% 
Glycerol  15%     pH 6.5            (0.1 M KOH) 
pH 5.8 (0.2M acetic acid)   
 
Both buffers were sterile-filtered and stored at 4ºC. 
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2.4.2 Transformation of competent cells with recombinant DNA 
Approximately 5L of a ligation reaction were mixed with a 25 L aliquot of competent 
E.coli DH5- (thawed on ice). The mix was incubated on ice for 30 min and heat-shocked in 
a water bath at 42ºC for 45 sec. 200μL of B medium was added and the cells incubated at 
37oC for 45 minutes. An aliquot of the transformation was spread out on LB-agar plates 
containing appropriate antibiotic (section 2.4.3.1.). 
 
Luria Bertani (LB) Medium  LB Medium + Agar (LB-Agar) 
Tryptone  10g/L   LB Medium 
Yeast extract  5g/L   Bacto-Agar   15g/L 
NaCl (170mM)  10g/L 
 
2.4.3 Selection of transformants 
2.4.3.1 Antibiotic selection  
To select for transformants, an aliquot of the transformation reaction was spread on LB-Agar 
plates containing appropriate antibiotic. Ampicillin was used at a final concentration of 
100μg/mL; kanamycin at 30μg/mL and chloramphenical at 20μg/mL. The antibiotics were 
added after the medium had cooled to about 50°C. 
2.4.3.2 Blue–White selection of recombinant bacteria 
Whenever a cloning plasmid contained a polylinker (MCS: multiple cloning site) within the 
-galactosidase gene, the cloning of an insert into this site disrupted the -galactosidase gene. 
Bacteria that are transformed with this recombinant DNA do not metabolize galactose, whose 
metabolic product is blue in the presence of IPTG. These colonies appear white after an 
overnight growth at 37ºC. Colonies transformed with wild type plasmid (plasmid without 
insert) give blue colonies. Plasmids with this color-selection system used in the work 
presented in this thesis are pBlueScript (Stratagene), pGEM-T (Promega) and p2T7TABlue. 
The transformed bacteria were streaked on LB-Agar plates supplemented with 1.5mgof X-Gal 
(a metabolisable analog of galactose) (80L of a 2% stock solution was spread on a plate 
ready to use) and 1mg of IPTG (5L of a 830mM stock solution was spread on the plate). 
Development of blue color of colonies was sometimes enhanced by a 1-2h incubation at 4ºC. 
A number of white colonies were screened for DNA inserts by colony PCR (Section 2.4.3.3), 
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DNA mini-preps (see 2.5.1) or restriction digests and agarose gel analysis. Putative clones 
were then confirmed by DNA sequencing. 
2% X-Gal       830 mM IPTG 
2 mg/mL in Dimethylformamide    2 g/10mL 
Stored in the dark at -20ºC     Stored at -20ºC 
 
2.4.3.3 Screening bacterial transformants by colony-PCR 
A PCR cocktail composed of PCR buffer, dNTPs, primers, and Taq-DNA polymerase and 
sufficient for the number of colonies to be screened was prepared. Twenty-four bacterial 
colonies were picked with the aid of a 10L-pipette tip and resuspended individually in 20μL 
of the PCR cocktail. Each colony was also patched onto a separate plate for reference. The 
reaction was incubated at 94oC for 10 min to lyse the cells and to inactivate nucleases. The 
amplification was done for 20-30 cycles in the RoboCycler® as follows: 94oC for 1 min, 55oC 
for 1 min, and 72oC for 1 min. The final extension was performed at 72oC for 10 min after 
which the reaction was held at 4oC. The products (10μL) were electrophoresed on a 1-1.2% 
ethidium bromide stained-agarose gel and visualized under UV. Clones were identified, larger 
quantities of DNA made (mini- or maxi DNA preps) and 8% glycerol stocks made and kept at 
–80oC.  
2.5 Analysis of transformants 
2.5.1 Plasmid DNA mini-preps  
All centrifugation steps were performed at RT. 
Up to 24 bacterial colonies were picked and resuspended individually into 3mL of LB 
supplemented with appropriate antibiotic. The cultures were incubated at 37oC with vigorous 
shaking for 12-16 hours. 1.5mL of the overnight cultures were centrifuged in an eppendorf 
tube at 13,000 rpm for 1min. The pellet was resuspended in alkaline lysis buffer of the 
Eppendorf FastPlasmidTM Mini kit (Eppendorf AG, Hamburg, Germany) and processed 
according to the manufacturers instructions. The DNA minipreps were screened for the 
desired clones by restriction endonuclease digestion, agarose gel analysis and confirmed by 
DNA sequencing at Medigenomix GmbH (Martinsried, Germany). A 100L aliquot of 
bacterial culture was mixed in a ratio of 1:1 with 16% glycerol in LB and kept at -80ºC. 
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2.5.2 Midi-preparation of plasmid DNA  
All centrifugation steps were performed at 4oC. 
After an overnight growth at 37ºC, up to 100 mL of bacterial culture were centrifuged at 
6,000 rpm for 10min (Sorvall, GSA rotor). The resulting pellet was carefully re-suspended in 
6mL of cold buffer P1 and transferred to an SS34-rotor centrifuge tube. 6mL of freshly 
prepared 0.2N NaOH/1% SDS were added, mixed and allowed to lyse the cells for 5 min. The 
lysate was mixed with 6mL buffer P3 and incubated on ice for 20 min. Large cellular 
fragments were separated by centrifugation at 13,000 rpm for 30min (Sorvall, SS34 rotor). 
The clear supernatant was passed through a column (Tip100, Qiagen) previously equilibriated 
with 4 0mL of buffer QBT. The column was washed twice with 20mL of buffer QC and the 
DNA eluted with 5 mL of buffer QF into a clean SS34-tube. The DNA was precipitated with 
3.5 mL of isopropanol and centrifuged at 11,000 rpm for 30min. The pellet was air-dried and 
re-suspended in 300μL of TE buffer and transferred into an eppendorf tube. The midi-prep 
DNA was used for a variety of downstream processes, e.g. transfections.  
 
Buffer P1       Buffer P3  
Tris-HCI   50mM (pH7.8)   KAc   3M 
EDTA   10mM (pH8.0)   Glacial Hac    (50% v/v)  
RNase A   100mg/L (Sigma)   pH 4.8 (acetic acid) 
 
Buffer QBT             Buffer QC   Buffer QF  
NaCl       0.75M NaCl  1M  NaCl   1.25M 
MOPS              50mM           MOPS  50mM   MOPS  50mM 
Ethanol             15%            Ethanol            15%  Ethanol  15% 
TritonX-100     0.15% 
pH 7.0              pH 8.2                                   pH 7.0 
 
2.5.3  Extraction of T. brucei genomic DNA 
All centrifugation steps were performed at RT. 
Between 3-10 x 107 cells were centrifugued at 2000 rpm for 10min. The cell pellet was 
resuspended in 150μL of Tris-EDTA-LiCl-Triton X-100 (TELT) buffer, mixed gently by 
inversion and incubated for 5 min. 150μL of equilibrated phenol-chloroform was added, 
mixed by vigorous shaking and centrifuged at 13,000 rpm for 5 min. The upper aqueous 
phase was aspirated into a new tube containing 500μL of 100% ethanol. The tube was swirled 
gently for 15 seconds, incubated for 5min and centrifuged at 13,000 rpm. The DNA pellet was 
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washed with 70% ethanol and air-dried. The pellet was then resuspended in 30-100μL of TE 
and incubated with RNase A for 30min. Ethanol precipitation was repeated to remove DNase 
A. 
TELT Buffer 
Tris.Cl  50mM (pH 8.0) 
EDTA  62.5mM (pH 9.0) 
LiCl  2.5mM 
Triton X-100 4% (v/v) 
 
2.5.4 Southern blotting and hybridization conditions 
Between 5-10g of genomic DNA was subjected to a single or double restriction enzyme 
digest in a total volume of 100L in conditions recommended by the suppliers. After an 
overnight digestion, a fresh aliquot of enzyme(s) was added and the reaction continued for 2 h 
to ensure complete digestion. The reaction was concentrated to 20L by ethanol precipitation 
and loaded onto an 0.8% agarose gel. Electrophoresis was run overnight at about 20V in 1 X 
TAE. The gel was photographed under UV light, rinsed briefly in water and depurinated in a 
tray of 0.25 M HCl with gentle agitation for 10 min. The gel was transferred into denaturing 
solution and gently agitated for 30 min. It was rinsed briefly in water and placed in 
neutralisation solution for 30 min with gentle agitation. The DNA was then transferred 
overnight to a nylon membrane (Hybond-N+, Amersham) by downward capillary blotting 
using a Turbo blotterTM apparatus (Schleicher & Schuell) and 10X SSC as transfer buffer. The 
blot was rinsed in 5 X SSC for 5min, air-dried and UV-crosslinked (UV Stratalinker 1800, 
Stratagene). The blot was prehybridized for 2 h in pre-hybridization solution. Hybridization 
was done overnight at 60ºC with 100ng of denatured -[32P]-labeled probe (Section 2.6.4) in 
hybridization solution. After hybridisation the membrane was washed 3 times each for 15 min 
in 10mL of wash buffer at 50oC.  The blot was exposed on an X-Omat X-ray film with 
intensifying screens and kept at –80oC for 2-5 days. 
 
 
Denaturing Solution    Prehybridisation Solution 
NaCl  1.5 M    5X Denhardt’s reagent 
NaOH  0.5M    6X SSC 
      0.5% SDS  
Herring Sperm DNA (Serva) 10μg/mL 
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Neutralizing Solution    Hybridization solution 
NaCl   1.5 M    5X Denhard’s reagent 
Tris-HCl  0.5 M (pH7.2)   6X SSC 
EDTA  1mM    0.5% SDS (w/v) 
                                                                       Herring Sperm DNA  10μg/mL 
20X SSC       
NaCl  3M     
Na-Citrate 0.3M 
pH 7.2 
 
50X Denhardt’s Solution    Southern blot wash buffer 
BSA    1% (w/v)   1X SSC 
Ficoll    1% (w/v)   0.5% SDS (w/v) 
Polyvynilpyrrolidone  1% (w/v) 
Filtered and stored at -20ºC 
 
DNA for probes or Herring sperm DNA was denatured by incubation at 95-100ºC for 5-
10min and immediately put on ice. The probe was saved and stored at -20ºC and again 
denatured before use. 
 
2.5.5  Cloning of TbRBP3 and AATP 3’-UTR 
The open reading frames of TbRBP3 gene was amplified by PCR using 427 pc genomic DNA 
and primers listed here. 
 
TbRBP3 (Tb11.03.0550) 
 
cz 1685 
Sense primer used to amplify of TbRBP3 ORF for over-expression. 
 
cz 1686 
Antisenese primer used to amplify of TbRBP3 for over-expression. 
 
cz 2335: 
GCTAAGCTTATGGAACCGGAGTGGAAAGTTTCCAGTAG 
Sense primer with a Hind III site used to amplify TbRBP3 for myc- and TAP tagging. It has a 
point mutation from G to T at 21 nt. to eliminate an internal Hind III site. 
 
cz 2336: 
GCTGTTAACATTCATTCTGCTGCTGCTGCTGC 
Antisense primer with a Hpa I site and without stop codon used to amplify TbRBP3 for TAP 
tagging. 
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cz 2342. 
GCAGGATCCATTCTGCTGCTGCTGCTCT 
Antisense primer with a Bam HI site and without stop codon used to amplify TbRBP3 for 
myc tagging, 
 
cz 2143 
CATCTCGAGTGGAACCGGAGTGTGAAAG 
Sense primer with an Xho I site for amplifying a 526 bp fragment of TbRBP3 for RNAi. 
 
cz 2144 
AGTGGATCCGCATTGTAAACATGGCGG 
Antisense primer with a Bam HI site for amplifying a 526 bp fragment of TbRBP3 for RNAi. 
 
cz 2425 
CAGGAGCTCCGTCACACATGCCTGAG 
Sense primer with a Sac II site to amplify 5’-UTR of TbRBP3 for V5 in situ tagging. 
 
cz 2430 
CAGCCGCGGCGTCACACATGCCTGAG 
Antisense primer with a Xba I site to amplify 5’-UTR of TbRBP3 for V5 in situ tagging. 
 
cz 2427 
GTACTCGAGATGGAACCCGGAGTGTG 
Sense primer with an Apa I site to amplify 5’ CDS of TbRBP3 for V5 in situ tagging. 
 
cz 2431 
GTAGGGCCCACGCTCTCAATGGAC 
Antisense primer with a Xho I site to amplify 5’ CDS of TbRBP3 for V5 in situ tagging. 
 
 
AATP 11 3’-UTR 
 
cz 1948 
ATATGTTAACCTCGAG(T)18(AGCT)3 
Oligo dT primer with Hpa I and Xho I sites used to define the AATP 3’-UTR. 
 
cz1951 
TTGGCTTTATATTCCCCGCACTCTTCATC 
Sense primer used to define the AATP 3’-UTR. 
 
cz 1952 
GTAAGGATCCGGAGGAGGCGGCGTAGCAGGAG 
Sense primer with a Bam HI site used to define and to amplify the AATP 3’-UTR. 
 
cz 2085 
TGAAGCATCCCCCTTATTCAACACCTC 
Antisense primer to amplify the region between 40-630 nt of the AATP 3’-UTR. 
 
cz2086 
TATTGTTAACAACAACGAAAATAAGACAAGTGG 
Sense primer with a Bam HI site to amplify the region between 40-630 nt the AATP 3’-UTR. 
Materials and methods 
 35
cz 2087 
AAATCAATGCGTACCAATTATTGATGCAA 
Antisense primer to amplify the region between 1-141 nt the AATP 3’-UTR. 
 
cz 2088 
AATTGGTAGGCATTGATTTATAGAGAC 
Sense primer to amplify the region between 260-833 nt the AATP3’-UTR. 
 
cz 2089 
ATATGTTAACCCCGAAAGTATCGCCTG 
Antisense primer with a Hpa I site to amplify deletions of the AATP3’-UTR. 
 
cz 2090 
TAAGAGCTCAGTGTCTCTCTATAATC 
Antisense primer to amplify the region between 1-290 nt the AATP 3’-UTR. 
 
cz 2091 
GACACTGAGCTCTTATTTCGTTCTGTTTGC 
Sense primer to amplify the region between 618-833 nt the aatter 3’-UTR. 
 
cz 2184 
TCCTCACGCAGCTCAGTGTCTTATAA 
Antisense primer to amplify the region between 1-290 nt the AATP 3’-UTR. 
 
cz 2185 
GAGCTGCGTGAGACTCAACCAATAC 
Sense primer to amplify the region between 350-833 nt the AATP 3’-UTR. 
 
 
cz 2186 
GAAAAGTTAGAAAGTATTGCTTGAGTCC 
Antisense primer to amplify the region between 350-833 nt the AATP 3’-UTR. 
 
cz 2187 
CTTTCTTAACTTTTCTCTTTTAATCTTG 
Sense primer to amplify the region between 420-833 nt the AATP 3’-UTR. 
 
cz 2190 
CGCGCTAGCAACTCACCAAGATTA 
Antisense primer to amplify the region between 610-833 nt the AATP 3’-UTR. 
cz 2191 
GAGTTGCTAGCGCGGCTCAATGGA 
Sense primer to amplify the region between 1-535 nt the AATP 3’-UTR. 
 
cz 2240 
ATCGTTAACAATGTTCCCCAATCA 
Antisense primer used to amplify the intergenic region of the AATP 11. 
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cz 2389 
GCTGGATCCGCGTCTTCCGTCCACTGAG 
Sense primer with a Bam HI site to amplify the region between 290-618 nt of the aatter 3’-
UTR. To use for cloning in pBS SKII. 
 
cz 2390 
GCTGTTAACACAAGTGGAGCAAATAAGAA 
Antisense primer with a Eco RI site to amplify the region between 290-618 nt of the aatter 3’-
UTR. To use for cloning in pBS SKII. 
 
cz 2436 
AGCTGGATCCGGCTTAGTATAGCGAGGTTTAGCTACACTCG 
Sense primer used to amplify J6f1f aptamer. 
 
cz 2437 
GCATGGATCCGAATTCGGCTCAGCACGAGTGTAGCTAAACC 
Antiense primer used to amplify J6f1f aptamer. 
 
cz 2489 
GCAAAGCTTATGTCCCCTATACTAGG 
Sense primer with a Hind III site to amplify ORF from GST. 
 
cz2490 
GCAGATCTCTCACGAGCGGCCGCT 
Antisense primer with a Hpa I site to amplify ORF from GST. 
 
cz 2497 
GCAAAAGCTTATGGCTTCTAACTTTACTCAG 
Sense primer with a Hind III site used to amplify MS2 coat protein. 
 
cz 2498 
GCAGGATCCATTAGTAGATGCCGGAGTTG 
Antisense primer with a Bam HI site used to amplify MS2 coat protein. 
 
cz 2514 
GCTAGTTAACCTTGTCCCGCTCGTCCAT 
Antisense primer with a Hpa I site for amplifying EGFP. 
cz 2585 
GCTGGGCCCATGGTGAGCAAGGGCGAGGAGTCT 
Sense primer with an Apa I site for amplifying EGFP 
 
cz 2583 
GCTAAGCTTATGGCCGCACAACACGACG 
Sense primer with a Hind III site used to amplify  N peptide. 
cz 2584 
GCTGGGCCCGGTGGCTAGCCCGCCGTTTGCAGC 
Antisense primer with an Apa I site used to amplify  N peptide. 
 
ORF-PCR products were cloned into pHD615 (for expression in pc cells, (Biebinger, Wirtz et 
al. 1997)),  pHD617 (bs, (Biebinger, Wirtz et al. 1997)), and into pHD918 (for TAP-tagging, 
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(Estevez, Kempf et al. 2001)). RNAi-fragments were cloned either into p2T7-177 (LaCount, 
Bruse et al. 2000). 
 
RT-PCRs and IPs 
 
cz 2478 
GAATGCCCTTATGTAAGTAA 
Sense primer to amplify Cyclin F box domain CDS. 
 
cz 2481 
CAGCAAATGGAGCACCACTG 
Antisense primer to amplify Cyclin F box domain CDS. 
 
cz 2578 
ATGTCGGACGAGGAACAAAC 
Sense primer to amplify actin CDS. 
 
cz 2579 
CGACTCGTCGTATTCACTCT 
Antisense primer to amplify actin CDS. 
 
cz 2719 
ATGTTATGCAGGTGGGGAAC 
Sense primer to amplify tubulin CDS. 
 
cz 2581 
CCTTTGGCACAACGTCACCACGG 
Anstisense primer to amplify tubulin CDS. 
 
 
cz  2232 
ACGCTGGTGCTACGCCTGAA 
Sense primer that anneals at the end of CAT ORF. 
 
 
czZFP-Fw 
TATAAAGCTTATGTCCTTCTCAATGAACACAG 
Sense primer to amplify CDS from Tb07.11L3.90. 
 
czZFP-Rev 
TAATGGATCCCTGCCCTAAAGAAGTTGCGC 
Antisense primer to amplify CDS from Tb07.11L3.90. 
 
cz2795 
GACAAGCTTATGCACATTTCAACACCC 
Sense primer to amplify CDS from ZFP1. 
 
cz2796 
GACGGATCCTCAATCCTCCAACCTTAC 
Antisense primer to amplfy CDS from ZFP1. 
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2.6 Isolation and analysis of RNA 
2.6.1 Extraction of T. brucei total RNA 
Total RNA was isolated from 2-4x107 cells from cultures with densities between 1-2 x 106 
cells/mL (bloodstream form) or 3-4 x 106 cells/mL (procyclics). The cells were centrifuged at 
2,000 rpm for 10 min at RT and the pellet resuspended in 1mL of pegGOLD TriFastTM 
(Peqlap, GmbH). 200L of chloroform was added and shaken vigorously and the tube stood 
at room temperature for 5 min. The mix was centrifuged at 13,000 rpm for 15min at 4°C. The 
aqueous phase was pipeted into 500L of isopropanol and RNA precipitated for about 30 min 
at RT. For use, the RNA pellet was redisolved into appropriate volume of RNAse-free water. 
Alternatively total RNA was isolated using RNeasy Mini/Midi Kit (Qiagen, Hilden, 
Germany) following the manufaturer’s instructions. 
2.6.2 Northern blotting 
Approximately 25μg of total RNA or 4μg of poly(A)+ RNA were precipitated with 1/10 
volumes of 3M NaAc (pH 5.4) and 2.5 volumes of ethanol for 15 min on ice. The tube was 
centrifuged at 13,000 rpm for 20 min at 4oC and the pellet washed with 750μL of 70% 
ethanol. The RNA pellet was dried on a heat block at 37oC for 5 min. 15μL of loading mix 
was added to the pellet and incubated at 37oC for 10 min. The tube was vortexed briefly to 
dissolve the RNA and incubated at 65oC for 10min, chilled on ice for 5 min and loaded on a 
gel. 5μg of molecular size marker (Invitrogen’s 0.24-9.4kb marker) were treated as the 
samples and loaded along side the samples. The RNA was resolved on a 1% 
agarose/formaldehyde gels at 18-20V in 1X MOPS. After electrophoresis, the gel was 
photographed under UV light and the RNA transferred onto a neutral nylon membrane 
(Nytran® Scheicher and Schuell) using the Turbo-blotter apparatus. The RNA was cross-
linked in UV light in a stratalinker (Stratagene). Prehybridisation was done for 2 hours at 
65oC in Northern blot Prehybridisation Buffer. Hybridisation was done overnight at 42oC with 
100ng of -[32P]-random-prime-labelled DNA probe. The blot was washed once in Wash 
Buffer I at room temperature for 30 min, then once in Wash Buffer II at 42oC for 45 minutes, 
and finally once in Wash Buffer III at 42oC for 30 minutes. The blot was exposed on an X-
Omat X-ray film with intensifying screens and kept at –80oC for 1-5 days. 
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10X MOPS buffer  RNA gel   RNA loading Mix 
MOPS   200mM  Agarose    1%(w/v)      Formamide    50%(v/v) 
Na-acetate  80mM  Formaldehyde 0.5M      Formaldehyde  6.5%(v/v) 
EDTA        10mM  1X MOPS       1X MOPS 
pH: 7.0            EtBr 10μg/mL 
 
Prehybridisation Buffer   Hybridisation Buffer 
5X Denhard’s reagent              Formamide  50% 
6X SSC     6X SSC 
1% SDS               1% SDS 
Herring Sperm DNA 100μg/mL            Herring Sperm DNA 100μg/mL 
 
Wash Buffer I  Wash Buffer II  Wash Buffer III 
10X SSC  1X SSC   0.1X SSC 
1% SDS  0.5% SDS              0.2% SDS 
 
2.6.3 Random prime labeling of DNA probes 
DNA probe labeling was done using the Prime-It II Random Primer labeling Kit (Stratagene) 
following the manufacturers intructions. Briefly, the DNA fragment to be labelled was diluted 
to 25ng/mL in TE. 4μL (100ng) was made up to 20μL with sterile water and the probe 
denatured at 95oC, 5 minutes and chilled on ice. To 1.5mL eppendorf tube in an ice bath, the 
following reagents were added in the following order: 
10μL Nucleotide mix 
5μL Primers 
20μL  Denatured DNA (100ng)  
1μL  Enzyme solution (Klenow 5U) 
3μL - [32P]-dCTP (30 μCi) 
11μL Sterile distilled water 
The contents were mixed gently by pipetting up and down and span briefly to collect the 
contents at the bottom of the tube. The reaction was incubated at 37oC for 1 hour. The probe 
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was then purified using the Nucleotide Removal Kit (Qiagen), following the manufaturer’s 
instructions.   
2.7 Isolation and analysis of T. brucei proteins 
2.7.1 Extraction of total protein 
All centrifugation steps were done at 4ºC. 2 x 106 cells were centrifuged at 2,500 rpm for 10 
min and washed with PBS (with complete protease inhibitor, Roche Applied Science) and re-
centrifuged. The supernatant was carefully aspirated leaving about 10-15μL of buffer. This 
was either stored at –20°C till used or an equal volume of 2 X Laemmli buffer was added and 
the sample denatured (by boiling for 95oC for 5 minutes) for SDS-PAGE. 
2.7.2 Determination of protein concentration by the Bradford protein assay  
The Bradford Assay is a rapid and accurate method commonly used to determine the total 
protein concentration of a sample. The assay is based on the observation that the absorbance 
maximum for an acidic solution of Coomassie Brilliant Blue G-250 shifts from 465 nm to 595 
nm when binding to protein occurs. Both hydrophobic and ionic interactions stabilize the 
anionic form of the dye, causing a visible color change. Within the linear range of the assay 
(~5-25 g/mL), the more protein present, the more Coomassie binds. Protein standards 
containing a range of 0 to 25g BSA were prepared from a stock of 1g/L to a standard 
volume of 1 mL (see Table 2.1). 
 
       Table 2.1 Preparation of a standard curve for protein determination 
Tube 1 2 3 4 5 6 
BSA (L) 0 5 10 15 20 25 
1M NaOH (L) 50 50 50 50 50 50 
Dist. Water (L) 950 945 940 935 930 925 
BSA (g/mL) 0 5 10 15 20 25 
 
The Bradford reaction was initiated by adding 800L, from the dilution series above, to 
200L of Bradford dye reagent in corresponding tubes labeled 1B to 6B. The reaction was 
incubated at room temperature for 5 min and the absorbance measured at 595 nm against the 
blank (tube 1B). A standard curve of absorbance versus BSA concentration was prepared and 
used to determine protein concentration in the test samples taking into consideration any 
dilution factor.  
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2.7.3 SDS-PAGE 
About 8mL 12% running gel were poured into a mounted mini protean electrophoresis 
apparatus (BioRad) overlayed with water and allowed to polymerise. 2.5 mL of stacking gel 
were then added and a comb slid between the glass plates. Once polymerised the gel was 
placed in electrophresis chamber and filled up with 1 X running buffer. Trypanosome samples 
(2x106 cells/lane) were loaded, the chamber connected to a power supply and proteins 
fractionated at 150V for about 45 min. 
 
12% Separating gel (15mL)             4% Stacking gel (5mL)  
Gel 30               6mL  Gel 30         0.65mL 
1.5M Tris-HCl (pH 8.8)         3.75mL          0.5M Tris-HCl (pH 6.8)    1.25mL 
Water               5.25mL Water                      3.05mL 
10% APS             50 μL  10% APS         25μL 
TEMED              10μL  TEMED          10μL 
 
10X Running buffer, 1L 
Tris (Roth)              30.3g 
Glycine (AppliChem)  188g 
10% SDS              100mL 
pH 8.3 
 
2.7.4 Western blotting 
All incubations and washes were at RT and with gentle agitation. Cell pellets of about 2x106 
cells each were resuspended in 1 X Laemmli buffer and denatured on a heating block at 95oC 
for 5 minutes. The samples were fractionated by SDS-PAGE and transferred to a polyvinyl 
diflouropyrolidol (PVDF) membrane (Hybond-P, Amersham). Blotting was done at 100V for 
1h at 40C in blotting buffer using a BioRad apparatus. The membrane was then incubated in 
blocking buffer (blotto) for 1 hour (RT), washed once for 15 min and then twice for 5min 
with fresh changes of wash buffer. It was then incubated for 1h in blocking solution 
supplemented with antibodies at appropriate dilution. The blots were again washed as before 
to remove unbound primary antibody. The filter was then incubated for 30 min with 
Horseradish peroxidase (HRP)-conjugated secondary antibody diluted at 1:1000 in blocking 
solution. Unbound antibody was washed off with PBS-T (15 min x1, then 5 min x4). Specific 
protein bands were visualized by incubating the membrane in ECLTM detection reagents 
(Amersham) for 1 min and exposing for 10 sec to 60 min on ECL films. The membranes were 
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stripped for re-probing by incubating in stripping buffer for 30 min at 500C and washing for 
10 min in excess PBS-T. 
Blotting buffer    PBS-T buffer pH 7.6 
Tris   25mM   Na2HPO4   10mM 
Glycine  192mM  KH2PO4   1.8mM 
Methanol  20%     NaCl    140mM 
  KCl    2.7mM 
 
Blocking solution   Tween-20 (Serva)  0.3% 
Skimmed milk 10% (in PBS-T)   
 
Stripping buffer  
Tris           62.5mM (pH 6.7)   
SDS            2%     
-mercaptoethanol  100mM 
 
2 X Laemmli buffer 
Tris.Cl   0.25M (pH 6.8) 
SDS   4%(w/v) 
Glycerol  20%(v/v) 
-Mercaptoethanol 3%(v/v) 
Bromophenol blue Trace 
 
2.7.5 Coomassie blue staining of SDS-PAGE gels 
All steps were performed at RT. The gel was soaked for 30 min in Coomassie blue staining 
solution (with gentle agitation). Gels were destained at least three times, for 1 h each, in high 
Methanol solution and further in Low Methanol solution for up to 12 h. For record purposes, 
the gel was transferred to a solution with 20% ethanol/10% glycerol for 30-45 min and then 
vacuum-dried. 
Coomassie blue staining solution 
Coomassie Brilliant Blue R250   0.25%(w/v) 
Methanol               45.4%(v/v) 
Glacial acetic acid               9.2%(v/v) 
 
High Methanol solution   Low Methanol solution 
Methanol   45.4%(v/v)   Methanol   5%(v/v) 
Glacial acetic acid  7.5%(v/v)   Glacial acetic acid  7.5%(v/v) 
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2.7.6 Preparation of dialysis tubes 
Dialysis tubes (MWCO 12000-14000) were cooked 10 min in 2% NaHCO3/1mM EDTA pH 
8,0 and rinsed with dH20, and cooked 10 min in 1mM EDTA. Storage was in the same 
solution at 4°C and rinsed with H2O before use. 
2.7.7 In vivo labeling with [35S]-Methionine 
All centrifugation steps were at RT. 2x107 cells were centrifuged for 10 min at 2,000 rpm and 
washed with 500μl labeling medium by centrifugation at 6'000 g for 2 min. The cell pellet 
was resuspended in 400μl and 150 mCi of [35S]-Methionine (Amersham, in vivo labeling 
grade, 10 mCi/ml) was added. Cells were incubated for 1hr at 37°C (bloodstream) or 30°C 
(procyclics) and washed 2x with normal medium (6'000g for 2 min). Pellets were stored at –
80°C until immunoprecipitation. 
 
 Labeling medium 
ISCOVE’s medium (Gibco) lacking Methionine, supplemented with 10mM glucose, 
1.5mM L-Cysteine (only for bloodstream), 0.14% b-mercaptoethanol (only for 
bloodstream), and 10% heat-inactivated FCS (previously dialysed against 30mM 
HEPES pH 7.3 /150mM NaCl. 
2.7.8 Immunoprecipitation 
All centrifugation steps were at 4°C, 5 min at 13'000 rpm; incubations were also at 4°C. Each 
[35S]-Methionine-labeled sample, kept at –80°C as pellets, was solubilised with 750μl 
solubilising buffer, placed for 30 min on ice (vortexing every 5-7 min) and centrifuged. The 
supernatant was put to rotate for 2 hrs or overnight with 40μl of Sepharose-protein A. After 
centrifugation, the supernatant was transferred to a new tube and incubated with the chosen 
antibody for 1 hr, also rotating, 40μl of Sepharose-protein A were added and centrifuged after 
2 hrs. The Sepharose pellet was washed six times: three times with 500μl of buffer A, two 
times with 500ml of buffer B, and once with 500ml of buffer C. The last pellet was 
resuspended in 45ml of Laemmli buffer and denatured for SDS-PAGE; 15 ml (2x106 cells) 
were loaded in each lane. Following fixation with Low Methanol Solution, the gel was soaked 
in 5x gel volume EN3HANCE (NEN, PerkinElmer) for 1 hr under gentle agitation. The used 
enhancer solution was discarded into an appropriate radioactive waste container. The gel was 
soaked in cold water and agitated for 45 min at 4°C, vacuum-dried (2 hrs at 80°C) and 
exposed to an X-ray film at –80°C. 
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solubilising buffer (10ml) 
50mM Tris-HCl pH 7.4 
500mM NaCl 
2% IGEPAL CA-630 (Sigma) 
1 tablet complete protease inhibitor (Roche) 
 
buffer A   buffer B   buffer C 
10mM Tris-HCl pH 7.5 10mM Tris-HCl pH 7.5       10mM Tris-HCl pH 7.5 
150mM NaCl   500mM NaCl 
0.2% IGEPAL CA-630 0.2% IGEPAL CA-630 
2mM EDTA   2mM EDTA 
 
Sepharose-protein A (Amersham Biosciences) 
0.5 g were hydrated for 1 hr in 200 ml of 100 mM Tris-HCl at 4°C and then washed with the 
same buffer. For storing, 0.02% Na-azide was added. Before use, the slurry was equilibrated 
in solution A. 
2.7.9  Immunoprecipitation to isolate mRNP complexes 
The protocol of Tenenbaum et al. was adapted to isolate mRNP complexes (Tenenbaum, 
Carson et al. 2000; Tenenbaum, Lager et al. 2002). To this end, 3x107cells expressing the 
tagged protein of interest and the CAT-ATTP 3’-UTR reporter construct were lysed in 400 L 
of polysome lysis buffer (100 mM KCl, 5 mM MgCl2, 10 mM Hepes, pH 7.0, 0.5% Nonidet 
P-40), including one tablet of complete inhibitor (without EDTA, Roche) and 200 units 
RNaseIn (Promega) and 5l Vanadyl Ribonucleoside complexes (Sigma). Pre-swollen IgA 
beads were preincubated with anti-I antisera for 2 hrs at 4°C in NT2 buffer (50 mM Tris, pH 
7.4, 150 mM NaCl, 1 mM MgCl2, 0.05% Nonidet-P 40) and washed 6 times with 1 ml of 
NT2 buffer.  50 L of the pre-coated beads were incubated with the lysate for 2 hr at 4°C with 
rotation. This step was repeated, and then the beads were collected by centrifugation and the 
lysate was incubated with 50 L of either anti-Myc sepharose or anti-GFP precoated IgA 
beads for 2 hr. The supernatant was collected,  the beads were washed 6 times with 1 mL of 
NT2 buffer and the mRNPs were eluted either by adding myc-peptide in NT2 buffer 
supplemented with 200 units RNasIn and 5l Vanadyl Ribonucleoside complexes (Sigma) 
and incubation for 20 min at 4°C, or just by adding 100 L of NT2-buffer. The eluate was 
supplemented with 0.1% SDS and 30 g proteinase K, and incubated for 30 min in a 55°C 
water bath. The immunoprecipitated RNA was isolated by phenol-chloroform-isoamyl 
alcohol extraction and ethanol precipitation.  
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2.8 Tobramycin affinity chromatography to isolate mRNPs. 
The protocol of Hartmuth et al. was followed (Hartmuth, Urlaub et al. 2002; Hartmuth, 
Vornlocher et al. 2004). 
 
2.8.1 Derivatization of the matrix 
1mL of a 5-mM tobramycin solution (0.2 M NaHCO3, 0.5 M NaCl, pH 8.3 (NaOH)) were the 
incubated by head-over-tail rotation overnight with 2 mL (packed volume) of N-
hydroxysuccinimide-activated Sepharose 4 Fast Flow (Amersham) previously washed four 
times with 9 mL 1mM HCl by gentle resuspension and brief centrifugation at 250g at 40C. 
After centrifugation at 250g (5 min) the supernatant was removed and 8 ml of blocking buffer 
A (0.2 M NaHCO3, 0.1 M NaCl,  1 M ethanolamine, pH 8.0 (HCl)) were added and incubated 
for 2 hours at room temperature, washed 3 times with PBS and twice with PBS containing 
NaN3 at 4
0C, and stored. 
 
2.8.2 Testing of the Tobramycin matrix 
For affinity selection, 4X binding buffer 4X BP (80 mM Tris_HCl, pH 8.1, 4 mM CaCl2, 4 
mM MgCl2, 2 mM DTT) was freshly prepared. The specificity of the interaction between the 
tobramycin aptamer present on the CAT-AATR 3’-UTR reporter mRNA and the matrix-bound 
tobramycin was monitored as follows: 50 μL of the tobramycin matrix was blocked with 400 
l of blocking buffer B (1X BP, 300 mM KCl, 0.1 mg/ml tRNA, 0.5 mg/ml BSA, 0.1% NP-
40) by head over tail (HOT) rotation overnight. The matrix was collected and and 400 L of a 
mixture containing 1 g of total RNA containing the  tobramycin-tagged RNA and 0.1 
mg/mL tRNA in binding buffer (1X BP, 145 mM KCl), were added to 15 L of matrix and 
incubated for 1.5 h at 40C. The matrix was collected, the supernatant saved. The matrix was 
then washed three times with 750 L ml of W145 buffer (1X BP, 145 mM KCl, 0.1% NP-40) 
and the bound RNA was eluted by incubating with 100 L of E145T elution buffer (1X BP, 
5mM tobramycin, 145 mM KCl, 2 mM MgCl2) with HOT rotation for 10 min. The RNA 
present in the supernatant and the eluted RNA were reversed transcribed and the cDNAs 
obtained were used as a template in a PCR reaction to amplify a fragment encompassing part 
of the CAT reporter gene, the tobramycin aptamer and part of the AATR 3’-UTR. 
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2.9 Tandem Affinity Purification (TAP) 
TAP purification was done as described in (Puig, Caspary et al. 2001) with minor 
modifications. 
2.9.1 Preparation of cell lysate for TAP purification 
Reserve and pre-cool centrifuge and rotor SS34 and ultracentrifuge 75Ti, all other tools pre-
cooled. For each TAP purification spin down 5x109 cells at 2000rpm at 4°C. Wash cells twice 
with 50ml ice-cold PBS. Snap freeze pellets in liquid Nitrogen and store at – 80°C or directly 
proceed with extract preparation. Break cells in a final volume of 6ml breakage buffer (10mM 
Tris-Cl, 10mM NaCl, 0.1% IGEPAL, adjusted to pH 7.8 with HCl) including one tablet of 
complete inhibitor (without EDTA, Roche) by passing 15-20 through a 21-25 gauge needle. 
Check on a glass slide to ensure complete breakage. Spin cell lysate at 10’000g for 15 min to 
remove cell debris. Transfer supernatant to pre-cooled Polycarbonate Thick Wall Beckman 
centrifuge tubes (13.5ml capacity, 355630 rec. No.). Spin at 35'000 rpm, 4°C, for 45 min. 
After centrifugation transfer supernatant to 15 ml Falcon. Measure volume and add NaCl to a 
final concentration of 0.14M (note that breakage buffer is already 0.01M NaCl). Mix and take 
25μl aliquot (start material, #1). 
2.9.2 TAP-Purification 
200μl IgG sepharose bead suspension (Amersham Biosciences) is transferred into a 0.8x4-cm 
Poly-Prep column (Bio-Rad) and washed with 10ml IPP150 (10mM Tris-Cl, pH 7.8, 150mM 
NaCl, 0.1% IGEPAL). The cleared cell lysate is adjusted to 10mM Tris-Cl, pH 7.8, 150mM 
NaCl, and 0.1% IGEPAL) and transferred into the column containing the washed beads and 
rotated for 2hrs at 4°C. Elution is done by gravity flow. 25μl of flow through (IgG flow 
through, #2) is taken for subsequent analysis. The beads are washed three times in 10ml of 
IPP150 and once with 10ml of TEV cleavage buffer (IPP150 adjusted to 0.5mM EDTA and 
1mM DTT). Cleavage is done in the same column by adding 1ml of TEV cleavage buffer and 
100 units of TEV protease (Gibco). The beads are rotated for 2hrs at 16°C and the eluate is 
recovered by gravity flow. Take 15μl aliquot (IgG eluate, #3). 
200μl of calmodulin affinity bead suspension is transferred to a column and washed three 
times with 10ml of IPP150 calmodulin binding buffer (10mM Tris-Cl, pH 7.8, 10mM -
mercaptoethanol, 150mM NaCl, 1mM magnesium acetate, 1mM imidazole, 2mM CaCl2, 
0.1% IGEPAL). Three mililiters of IPP150 calmodulin binding buffer and 3 μl of 1M CaCl2 
are added to the 1 ml of eluate recovered after TEV cleavage. This solution is transferred to 
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the column containing washed calmodulin beads and rotated for 1 h at 4°C. Beads are washed 
three times with IPP150 calmoduling binding buffer. The bound proteins are eluted with 1 ml 
of IPP150 calmodulin elution buffer (10mM Tris-Cl, pH 7.8, 10mM -mercaptoethanol, 
150mM NaCl, 1mM magnesium acetate, 1mM imidazole, 2mM CaCl2, 0.1% IGEPAL, 2mM 
EGTA). The eluate is concentrated by TCA precipitation. 
2.9.3 TAP purification to isolate mRNP complexes 
The TAP purification method was also used to isolate mRNP complexes. The protocol of 
(Gerber, Herschlag et al. 2004) was adapted. To this end, 1x109 cells expressing the TAP-
tagged protein of interest were lysed in 6 ml breakage buffer (see 2.10.1.), supplemented with 
200 units RNaseIn (Promega) and 5l Vanadyl Ribonucleoside complexes (Sigma). Binding, 
washing, and TEV cleavage were done as described in 2.10.1., but TEV cleavage buffer was 
supplemented with 200 units of RNasIn and 5l Vanadyl Ribonucleoside complexes (Sigma). 
The eluate after the TEV cleavage was supplemented with 0.1% SDS and 30 g proteinase K, 
and incubated for 30 min in a 55°C water bath. The immunoprecipitated RNA was isolated by 
phenol-chloroform-isoamyl alcohol extraction and ethanol precipitation. Note, that mRNP 
complexes can be isolated from all cells which express epitope-tagged mRNA binding 
proteins using immunoprecipitation (see, (Tenenbaum, Carson et al. 2000; Tenenbaum, Lager 
et al. 2002)). Negative controls were applied either by using cell lines expressing only the 
TAP-tag or using cell lines expressing an untagged version of the mRNA binding protein of 
interest. 
2.10 Electrophoresis mobility shift assay (EMSA) 
EMSA was done as described in (D'Orso and Frasch 2001) with minor modifications. 
 
2.10.1 In Vitro Transcription 
The region encompassing the nt 290-618 of the AATR 3’-UTR, was amplified by PCR and 
cloned into the BamHI and EcoRI sites of the vector pBS(KS) (Stratagene). Transcription of 
sense and antisense sequences was performed with the MAXIscript In vitro transcription kit 
(Ambion) following the instructions of the manufacturer. 1 g of XhoI and XbaI-digested 
plasmid was transcribed using T3 or T7 RNA-polymerase in the presence of [-32P]UTP 
(800 Ci/mmol, Amersham) and 500 M ATP, CTP, and GTP and incubated for 30 min at 
40C. The transcripts were purified on an 8 M urea-6% polyacrylamide gel and eluted 
overnight in RNA elution buffer (0.3 M NaOAc, 10 mM MgCl2, and 1 mM EDTA).  
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2.10.2 Protein Extract Preparation 
For total protein extract preparation,  2.5x108 parasites were resuspended in 1 ml of lysis 
buffer (25mM Hepes pH 7.6, 5 mM MgCl2, 1.5 mM KCl, 2 mM DTT, 10 mM, 0.1% 
Nonidet-P40) supplemented with one tablet of complete inhibitor (without EDTA, Roche). 
After 30 min on ice, the extract was centrifuged at 13,000 rpm and the supernatant was stored 
at -70 °C. 
 
2.10.3 Heparin-Agarose Chromatography 
A column containing 2 ml of Affi-Gel heparin gel (Bio-Rad) was equilibrated with 10 bed 
volumes of Buffer D (20 mM Hepes pH 7.9, 20% Glycerol, 0.2 mM EDTA, 0.5 mM DTT and 
100 mM KCl). 1 mL of total protein extract was applied and the column was washed with 
Buffer D and the protein was eluted with a KCl linear gradient (0.1to 2M KCl in application 
buffer). 1 mL fractions were collected and O.D.280 nm measured. Peaked fractions were 
pooled, desalted using Millipore columns and used mobility assays. 
 
2.10.4 Analysis of RNA-Protein Interactions 
Binding reactions were performed with 30 g of trypanosome total extract (prepared as 
above), 10,000 cpm of RNA probe, 10 mM Tris-HCl (pH 7.6), 5% glycerol, 100 mM KCl, 5 
mM MgCl2, 1 g/ml bovine serum albumin, 500 ng/L tRNA (Sigma) in a 20 L final 
volume. The incubation time was 20 min at 25 °C. Each reaction was loaded directly onto a 
4% acrylamide-bisacrylamide (38:2), 0.5% TBE non-denaturing gel to perform an 
electrophoresis mobility shift assay (EMSA). The gels were dried and exposed to film at -70 
°C. 
2.11 Microarray 
Microarray analysis was performed as described in (Diehl, Diehl et al. 2002) with some 
modification. 
2.11.1 Genomic T. brucei microarray 
Genomic T. brucei microarrays were generated by Stefanie Brems at the DKFZ (Deutsches 
Krebsforschungszentrum, Heidelberg, Germany). In brief, 24,567 random shotgun clones 
representing the genome of T. brucei brucei strain TREU927/4 were provided by Najib El-
Sayed of the Institute for Genomic Research (TIGR, Rockville, USA). These clones were 
PCR amplified in 384- or 96-well microtitre plates using primers 
d(TTGTAAAACGACGGCCAGTG) and d(GCGGATAACAATTTCACACAGGA), which 
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are flanking the multiple cloning site of vector pUC18. The PCR products were checked by 
agarose gel electrophoresis. 
DNA fragments were spotted onto poly-L-lysine coated glass slides as described in (Diehl, 
Diehl et al. 2002). Spotting was done with an SDDC-2 DNA Micro-Arrayer from Engineering 
Services Inc. (Toronto, Canada) and SMP-3 pins (TeleChem International Inc., Sunnyvale, 
USA). Subsequently, the slides were cross-linked using UVC-500 (Hoefer Scientific 
Instruments, San Francisco, USA). 
2.11.2 Sample preparation, labeling and hybridisation 
Total RNA from 4x108 exponentially growing cells (below 1x106 cells/ml for bloodstream 
forms and 2x106 cells/ml for procyclics) was isolated using Qiagen RNeasy Midi Kit. 15μg of 
total RNA was reverse transcribed using SuperScriptTM III (Invitrogen). The following 
protocol for a 40-μl reaction volume was used: 
 
1.    Add the following components to a nuclease-free microcentrifuge tube: 
5μl  of oligo(dT)12-18 (100ng/μl) (500ng) 
15μg   of total RNA 
3μl  dAGT-mix (10mM) 
2μl  dCTP (1mM) 
2μl  Cy3/Cy5-dCTP (1mM) 
RNase free water to 27μl 
2. Heat mixture to 65°C for 5 min. and incubate on ice for at least 1 min. 
3. Collect the contents of tube by brief centrifugation and add: 
 8μl   5x First-Strand Buffer 
 2μl   0.1 M DTT 
 1μl  RNAseInTM  (Promega) 
                       2μl  SuperScriptTM III RT (200 units/μl) 
4. Mix by pipetting gently up and down. If using random primers, inc. 
 tube at 25°C for 5 min. 
5. Incubate in the dark at 50°C for at least 3hrs (or overnight). 
6. Inactivate the reaction by heating at 70°C for 15 min. 
7. Add 1μl RNaseH (Roche). 
8. Incubate 20 min. at 37°C. 
9. Use QIAquick PCR Purification Kit (QIAGEN, Hilden, Germany). 
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10. Elute cDNA with 2 x 50μl RNase free water. 
11. Measure cDNA concentration. 
12. Ethanol-precipitate cDNA. 
13. Resuspend cDNA-pellet in 5μl TE, vortex. 
 
Prehybridisation/Hybridisation: 
14. Wash DNA chip 10 sec. in 0.2% SDS, 10 sec. in dH20, and 3 min in 95°C 
dH20. 
15. Place slide into Atlas Glass Hybridization chamber (DNA-Array side up!) and 
fill with 2ml Prehybridisation Buffer (5x SSC, 0.1% SDS, 1% BSA) 
16. Incubate for 45 min at 55°C. 
17. Wash the slide by dipping 3x in dH20 at RT. 
18. Dip the slide in Isopropanol (abs.) and dry. Slides should be used immediately 
after prehybrisation. 
19. Mix Cy3- and the corresponding Cy5-labelled cDNA and denature at 95°C for 
5 min. Immediately put sample on ice. Quickspin. 
20. Add 60μl of hybridisation buffer (50% formamide, 3x SSC, 1% SDS, 5x 
Denhardt’s reagent and 5% dextran sulfate). 
21. Spread hybridisation mix over glass slide. Cover with cover slip, and hybridize 
o/n in a dark humidified chamber at 62°C. 
22. Wash the slides at  RT: 10 min in Washing Buffer 1 (2x SSC, 0.2% SDS), 10 
min Washing Buffer 2 (2x SSC), and 10 min in Washing Buffer 3 (0,2x SSC). 
Dry slides. 
2.11.3 Image acquisition and data analysis 
DNA chips were scanned with ScanArray 5000 (Packard BioScience, Dreieich, Germany) 
subsequently with Cy3- and Cy5-channel at a resolution of 10μm. Analysis of resulting image 
were performed using GenePix software (Axon Instruments, Union City, USA) to generate 
numerical values of spot signal intensities. The software package MCHIPS  (Fellenberg, 
Hauser et al. 2002) was used for data quality assessment and normalisation. Differentially 
regulated transcripts were confirmed by Northern blot analyses. 
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2.12 Indirect immunofluorescence assay (IFA) 
All steps were done at RT; washes are for 5 min, with gentle agitation. About 1x106 cells 
were centrifuged for 10 min at 2,000 rpm and resuspended in 4 mL of 1X PBS containing 4% 
Paraformaldehyde. This parasite suspension was distributed in a four-chambered slide 
(Falcon) for fixation. After 25 min, the fixation solution was aspirated and the chambers 
washed with PBS. If the experiment had to be suspended at this point, the slides were kept at 
40C with the cells immersed in PBS containing 0.2% sodium azide. On resumption, this 
buffer was discarded and the slides rinsed with PBS. Cells were then permeabilised by 
incubating in 0.2% Triton X-100 in PBS for 20 min. After washing, the cells were incubated 
in blocking solution (0.5% gelatin in PBS) for 20 min. Fixed, permeabilised cells were then 
incubated 1h in an appropriate dilution (1:500 to 1:1000) of the appropriate primary antibody 
in gelatin/PBS solution. The cells were washed twice with Triton X-100/PBS and incubated 
with the corresponding secondary antibody (anti-rabbit or anti-mouse IgG, Alexa-flour 
conjugated) in gelatin/PBS solution 30min. After two washes with 0.2% Triton X-100/PBS 
solution, the nucleic acids of the cells were stained for 10 min with DAPI (4’, 6’-diamidino-2-
phenylindole, 200ng/mL in PBS). The slides were washed once with PBS and air-dried. 
Controls were stained with antibodies or dyes individually to confirm that no fluorescence 
light was bleeding into the other channels. The chamber walls were peeled off and the slides 
mounted with a drop of 84% glycerol in PBS on each field.  Cells were examined with a 
Leica DM RXA microscope equipped with Deconvulsion Software Openlab (Improvision). 
Images were recorded using a Hamamatsu digital CCD camera (Hamamatsu Photonics K.K., 
Japan). Processing and pseudo-colouring and merging of images were performed using Adobe 
Fotoshop software (version 7, Adobe Systems Incorporated). 
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3  Results 
 
3.1 Characterisation of TbRBP3 
 
3.1.1 Identification of TbRBP3 
One of the main topics in the lab is to study the mechanisms involved in mRNA degradation 
in Trypanosoma brucei. This aspect is relevant for the control of developmentally regulated 
mRNAs. The role of RRM-type RNA binding proteins in these mechanisms is well 
established and although BLAST search on the T. brucei genomic database predicts the 
presence of 75 of these proteins, the role of most of them has not been established. This work 
started with the characterisation of the T. brucei homologues of T. cruzi U- rich binding 
proteins 1 and 2 that bind the 3’-UTR of T. cruzi small mucin genes (Tcsmug) mRNAs and 
target them for degradation. By searching the T. brucei genome database 
(http://www.genedb.org/) it was possible to find another homologue of this family of proteins, 
that we named RNA Binding Protein 3 or TbRBP3 (Tb11.03.0550). 
 
The TbRBP3 gene is located on chromosome 11 approximately 10 kb upstream of the 
TbUBP2 gene. TbRBP3 is a predicted protein composed of 200 amino acids and with a 
molecular weight of 22.3 kDa. The RRM recognition motif is located between the protein 
residues 80-151. The protein shares 59.8% identity with TcRBP3 (Tc00.1047053507093.250). 
Using the amino acid sequence of the TbRBP3 as a query in BLASTP analysis, 2 other 
homologues of the protein were also found in other Trypanosomatids (congo1375b07.q1k_4 
in T. congolense and LmjF25.0520 in Leishmania major). These sequences and TbUBP1 
(Tb11.03.0620 ), TbUBP2 (Tb11.03.0580), TcUBP1 (Tc00.1047053507093.220) and 
TcUBP2 (Tc00.1047053507093.229) were chosen and compared using ClustalW. The 
corresponding   alignment is shown in figure 3.1.1.  The presence of 3 different domains 
stands out: the highly conserved RRM recognition motif in the central part of the proteins and 
2 poorly conserved domains at the N- and C- terminal regions that might be involved in 
protein-protein interactions.  
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Fig. 3.1.1 RBP3 is present in different Trypanosomatids. ClustalW alignment of RBP3 homologues present in 
different species of trypanosomatids (T. brucei RBP3 accession number Tb11.03.0550, T.cruzi 
(Tc00.1047053507093.250), L.major (Lm.jF25.0520) and T. congolense (congo1375b07.qlk_4). TbUBP1 and 2 
and TcUBP1 and 2, -which are involved in developmentally regulated gene expression control- were also 
compared. Conserved residues (the RRM-motif and in particular the RNP1 binding motif is underlined) are 
colored black. Less conserved amino acids are highlighted grey (weak homology is observed at the N- and C-
terminal domains of the protein). 
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3.1.2 TbRBP3 has a role in bloodstream stage T. brucei 
 
3.1.2.1 Over-expression of TbRBP3  
In order to determine if TbRBP3 is differentially expressed in both life stages of 
Trypanosoma, 10 μg RNA of each were run on a formaldehyde gel, transferred to a nylon 
membrane and hybridized with a 32P-labeled probe corresponding to TbRBP3 ORF.  As a 
loading control, the membrane was also hybridized with SRP (signal recognition particle). 
The results of this Northern blot are shown in figure 3.1.2. A band of 4 kb corresponding to 
TbRBP3 RNA was obtained. After normalization, it can be observed that the mRNA steady-
state levels are equal in both life stages of the parasite (figure 3.1.2). This figure is part of the 
northern blot shown in figure 3.1.3. It was not possible to determine if the protein was also 
differentially expressed due to the lack of a specific antibody, but later studies using in situ 
V5 tagged-RBP3 demonstrated that this protein is expressed equally in both life stages of the 
parasite (see figure 3.1.6).  
 
 
 
 
 
To get insight into the function of TbRBP3, the protein was first over-expressed in both 
procyclic and bloodstream forms. For this, Claudia Hartmann, a member of the lab, amplified 
by PCR the entire TbRBP3 ORF using the primers cz1685 and cz1686, gel purified it and 
cloned it HindIII/BamHI into pHD617 (containing actin 3'UTR, for expression in PC) or 
pHD615 (containing VSG 3’UTR, for expression in BS) generating the plasmids pHD1323 and 
pHD1324. Then I continued the experiments.  10 μg of each DNA were cut with Not I, and the 
linearised plasmids were used to transfect T. brucei 449 PC and BS cells which contain the Tet 
repressor. The selection of the transformed parasites was done by adding hygromycin to the 
growth media. 
 
Fig. 3.1.2 TbRBP3 mRNA is approximately equally expressed 
in both life stages of T. brucei. Northern blot analysis with 10μg 
of total RNA from T. brucei 449 BS and PC and hybridised with 
a 32P labeled probe recognising TbRRP3.  SRP was used as a 
loading control. 
 1      0.85 
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After selection the recombinant expression of TbRBP3 was induced by addition of tetracycline 
(100 ng/mL) and total RNA was prepared after 48 hours. The presence of the new transcript was 
assessed by northern blot using a TbRBP3 specific probe. The results are shown in figure 3.1.3. 
Two additional transcripts were detected apart from the endogenous one: one of the expected 
size (0.9 kb in BS and 1 kb in PC) and a shorter one (150 bp lower), which suggests that the 
transcripts were alternatively processed.  The size of the recombinantly expressed transcript was 
different between PC and BS. This difference was due to the size of the 3’-UTR which was used 
for optimal expression in the two cellular stages. 
 
 
 
 
To assess if the increased levels of TbRBP3 had a visible phenotypic effect, over-expression 
of the protein was induced and the cell growth monitored every 24 hours during one week 
(Figure 3.1.4). If TbRBP3 is over-expressed in procyclics, it does not affect growth and also 
has no apparent effect on morphology.  In contrast, the cell growth of bloodstream forms was 
impaired. The doubling time of these cells increased by 50% when the exogenous TbRBP3 
was present (doubling time was 11.3 hrs vs. 8 hrs in the wild type). This indicated that 
TbRBP3 might play an important role in this life stage.  
 
 
 
 
Fig. 3.1.3 Over-expressed TbRBP3 mRNA is present in 
bloodstream forms as well as in procyclic forms. Northern blot 
analysis with 10μg of total RNA from T. brucei 449 BS and PC 
and hybridized with a 32P labeled probe recognizing TbRRP3. 
SRP was used as a loading control. 
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3.1.2.2 RNAi  
RNA interference is a potent tool for studying gene function. This mechanism is used by T. 
brucei to regulate the transcript abundance of retroposons and the process currently represents 
the method of choice in gene function studies of the parasite (Djikeng, Shi et al. 2001; Ullu, 
Djikeng et al. 2002; Motyka and Englund 2004; Ullu, Tschudi et al. 2004). 
As a second approach to investigate the role of TbRBP3, the protein level was decreased by 
RNAi in bloodstream and procyclic cells according to the procedure of the T.brucei functional 
genomics project (TrypanoFAN http://trypanofan.path.cam.ac.uk/cgi-
bin/WebObjects/trypanofan).  To select the region of the transcript to be targeted, RNAit 
software was used (Redmond, Vadivelu et al. 2003) and the primers were selected using the 
MIT’s primer3 program (http://wwwgenome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi) 
and NCBI blast (http://www.ncbi.nlm.nih.gov/BLAST/). A 525-bp fragment was amplified by 
PCR using the primers cz2143 and cz2144 and the PCR product was cloned between two 
opposing and inducible T7 promoters in p2T7-177 XhoI/BamHI (LaCount, Bruse et al. 2000). 
The resulting plasmid (pHD1638) was transfected into T. brucei 427 1313/514 bloodstream 
and procyclic cell lines. 
 
Fig. 3.1.4 Effect of over-expression of 
TbRBP3 on cell growth. PC and BS cell 
lines over expressing TbRBP3 were grown 
in the absence (blue line) or presence (pink 
line) of tetracycline and growth monitored 
for one week. Cells were diluted every day 
to a density of 2x105 cells/ml for BS and to 
5x105cells/ml for PC. 
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To check the depletion of TbRBP3 Northern blot analysis was performed. After 24 hours of 
RNAi induction the TbRBP3 mRNA levels decreased in both procyclic and bloodstream 
forms, although approximately 30% of the transcript still remained (Figure 3.1.5 A). RNAi 
induced cells were grown in the presence of tetraycline for one week and growth was 
monitored every 24 hours (figure 3.1.5 C).  Silencing of TbRBP3 had similar effects on cell 
growth as it was observed for the over-expression: the growth of bloodstream cells was 
impaired, while the growth rate in procyclics did not change. This suggests that this protein 
might play a functional role in this specific stage.  The depletion of the protein in BS was 
confirmed by Western blot of cell extracts from BS containing an in situ V5-tagged RBP3 and 
cotransfected with the dsRNAi RBP3 plasmid.   After 24 hours, the levels of the protein were 
decreased (Figure 3.1.5 B). 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.1.5 Knock down of TbRBP3 affects BS growth. A. Northern blot of BS and PC after induction 
of the dsRNA.  B. Western blot of an in situ tagged V5-TbRBP3 in BS after induction of dsRNA RBP3. 
C. Cell growth curve. 
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3.1.3 Cellular localisation of TbRBP3 
Due to lack of an antibody specific for TbRBP3, I over expressed both a myc- and a TAP-
tagged version of the protein and then assessed the localisation by cellular fractionation and 
immunofluorescence. For this purpose, the plasmids pHD1484 (C-terminal myc-tag) and 
pHD918 (C-terminal TAP-tag) were used.  In order to eliminate an internal Hind III cutting 
site located at 20 nt in the coding sequence of TbRBP3, a silent point mutation was introduced 
by PCR. Then the ORF without the stop codon was cloned between HindIII/BamHI sites for 
the myc-tagged, and between HindIII/HpaI sites for the TAP-tagged version. BS and PC cells 
were transfected and selected by adding hygromycin. Western blot analysis after cellular 
fractionation showed that the myc-tagged TbRBP3 is present in the cytoplasm of PC. This 
was confirmed by immunofluorescence microscopy using an anti-myc antibody. Attempts to 
express the fusion protein in BS of the parasite were unsuccessful (data not shown), although 
resistant-clones were obtained, the protein was not expressed. To look at the localisation of 
the protein in BS, we used a cell line containing a C-terminal TAP-tagged TbRBP3. The 
TAP-tag consists of two IgG binding units of Protein A (ZZ domains), a tobacco etch virus 
(TEV) protease cleavage site, and a calmodulin binding domain (Rigaut, Shevchenko et al. 
1999; Puig, Caspary et al. 2001). Western blot analysis using PAP antibody (peroxidise anti-
peroxidase) showed that the over expressed protein is mainly located in the cytosol of the 
parasite. Immunofluorescence microscopy showed that the protein is concentrated at the 
perinuclear space. This could however also be a false impression because the cells are thickest 
around the nucleus.  
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Fig. 3.1.6 TbRBP3 is mostly localised at the cytosol of T. brucei in procyclic and bloodstream forms. 
A. Immunofluorescence of BS and PC cell lines containing either V5 in situ-RBP3 or  over-expressed RBP3. 
B. Cell fractionation. 
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To avoid any artefact due to the over-expression of TbRBP3, a V5- in situ tagging of the protein 
was performed in BS and PC by homologous recombination. For this purpose, a cassette 
containing the blasticidin resistance marker (BSD) and a V5 tag (Shen, Arhin et al. 2001) was 
inserted between the 5’-UTR and the TbRBP3 coding region. Briefly, 2 DNA fragments- one 
corresponding to 200 bp upstream of the ATG start codon  and another spanning the first 300 bp 
of the TbRBP3 ORF were amplified by PCR  using T. brucei genomic DNA as a template. 
These fragments were sequentially ligated into the plasmid pBS:BSD-V5 to flank the blasticidin 
(BSD) marker and the V5 tag cassette to generate pHD1682. The flanking homology regions 
allowed a locus-specific recombination between wild-type chromosomal DNA containing the 
TbRBP3 gene and the linear DNA fragment containing the resistance marker. Bloodstream form 
1313/514 cells were transfected with SacII/ApaI linearised pHD1682 (TbRBP3 5’-UTR-Bsd-
V5-TbRBP3 CDR) and selected for resistance to blasticidin.  
 
 
Fig. 3.1.7 Construct for V5-TbRBP3 in situ tagging. 
 
This allowed us to confirm the data obtained with the over-expressed constructs. Therefore we 
conclude that TbRBP3 is mainly located in the cytosolic compartment. 
 
3.1.4 Looking for possible roles of TbRBP3 
 
3.1.4.1 Microarray analysis of TbRBP3 over expressing or knock-down cells: 
Considering the fact that both over-expression and knock-down of TbRBP3 impairs the 
growth of bloodstream forms, it is possible that this RNA binding protein is involved in the 
regulation of specific mRNAs in this life stage.  To test this, we used T. brucei specific 
genomic DNA microarrays (Diehl, Diehl et al. 2002; Brems, Guilbride et al. 2005) to 
compare the transcript levels of T. brucei wild-type bloodstream cells with BS cells where 
TbRBP3-levels were either elevated or depleted. Total RNA was isolated from uninduced and 
induced cells (for either TbRBP3- over-expression or the RNAi) and reverse transcribed with 
Cy3 and Cy5-labeled dCTP. After purification these cDNAs were used as a probe to hybridise 
the microarrays. Six independent hybridisations were performed for each TbRBP3 RNAi or 
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over-expression cell line. The data was analyzed using M-CHiPS software (Multi-Conditional 
Hybridization Intensity Processing System) (Fellenberg, Hauser et al. 2002). The spots that 
were more than 2.5 fold up or down-regulated were considered and some of them were 
sequenced (table 3.1).  Surprisingly, the transcript corresponding to TbRBP3 was not found in 
the analysis: it was neither upregulated in the microarrays in which the RNA from the over-
expressed cell line was used as a probe nor down-regulated in the RNAi cell line.  Since the 
microarrays used randomly cover 1.3 times the genome of T. brucei, it is possible that the 
TbRBP3 gene is not represented on the slides. 
Over-expression of TbRBP3 in bloodstream cells resulted in differential regulation of several 
transcripts, 2 of them were derived from VSG expression sites, and an amino acid transporter 
which has previously been found to be upregulated in bloodstream forms. Northern blots were 
done to confirm these data, but unfortunately they failed to show the differential expression of 
these transcripts. Similar results were obtained when cDNA derived from TbRBP3 RNAi 
cells was used. Of the several clones we selected only one, corresponding to Tb927.1.3250 
(clone 1M10). It was affected in both cases: Its mRNA levels increased 2.5 fold when 
TbRBP3 was over-expressed and decreased 2.7 fold after the knock-down. However, the 
transcript levels did not show any alteration when assessed by Northern blot. Figure 3.1.8 
shows the results for this target with the microarray picture and the Northern blot. In contrast 
to previous analysis done in the lab suggesting that the integration of the over-expression 
plasmid into the rRNA spacer regions affects the transcripts nearby, just one of my transcripts 
(1M10) was located in chromosome 1. 
 
 
 
 
 
Fig. 3.1.8  Is 1M10 a false positive? A. Microarray showing  upregulation of the spot 1 M 10 
(putative sugar transporter after over-expression of TbRBP3. B. Northern blot showing that the 
mRNA levels of 1 M 10 did not change after over-expression of TbRBP3. 
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Clone 
Accession 
number 
Characteristics Location Array 
data 
Northern 
data 
Other 
Over-
expressed 
TbRBP3 
      
1_M_10 
 
Tb927.1.3250 
 
 
Sugar 
transporter 
protein 
 
chr. 1 
 
+2,4 
 
1 RNAi growth 
defect in BS 
(Subramaniam, 
Veazey et al. 
2006) 
5307 bp 
1_E_4 
 
Tb11.01.2260 Intermediate 
filament protein 
chr. 11 
 
+3,05 
 
N.D 1818 bp 
2_P_20 
 
 
Tb927.4.2750 Hypothetical 
protein 
chr. 4 
 
+4,49 
 
1 900 bp 
 
11_C_1 
 
Tb927.6.1860 Rybosome 
recycling factor 
 
chr. 6 
 
+2,8 
 
 1029 bp 
 
15_C_9 
 
Tb11.0360 
 
Gp63-3 surface 
protease 
homolog, 
putative 
 
chr. 1 +3,18 
 
1 
 
1893 bp 
+1,64 (in 
microarray 
analysis of   
TbRBP3-RNAi 
BS but not 
confirmed by 
northern blot) 
20_C_10 Tb927.7.3260 
 
expression site-
associated gene 
7 (ESAG7) 
protein, putative 
 
chr. 7 
 
 1 1020 bp 
+1,73 (in 
microarray 
analysis of 
TbRBP3 RNAi 
BS but not 
confirmed by 
northern blot) 
 
47_D_10 
 
Tb927.3.1470 
 
variant surface 
glycoprotein 
(VSG)-related, 
putative 
 
chr. 3 
 
+2,8 
 
+1,26 
 
1098 bp 
+2,64 (in 
microarray 
analysis of  
TbRBP3 RNAi 
BSbut not 
confirmed by 
northern blot) 
48_K_13 
 
 
Tb927.4.4850 
 
amino acid 
transporter, 
putative 
 
chr. 4 
 
+2,5 
 
1 1353 bp 
-4.2 
(downregulation 
in BS) 
 
Table 3.1 Positive clones for the microarray analysis of over-expressed and knocked down 
TbRBP3. 
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Clone 
 
Accession 
number 
Characteristics Location Array 
data 
Northern 
data 
Other 
knocked-
down 
TbRBP3 
      
1_M_10 
 
Tb927.1.3250 
 
Sugar 
transporter 
protein 
Intermediate 
filament protein 
 
chr.  1 
 
-2,74 
 
1 RNAi growth 
defect in 
BS(Subramaniam, 
Veazey et al. 
2006)5307 bp 
 
13_E_9 
 
Tb10.6k15.2000 
 
chaperone 
protein DNAJ, 
putative 
 
chr.  10 
 
-3,5 
 
 1011 bp 
Upregulated in 
PC 
13_ P_ 7 
 
Tb10.70.4060 
 
60S acidic 
ribosomal 
protein P2, 
putative 
 
chr. 10 
 
-3,12 
 
0,7 345 bp 
 
29_P_4 
 
Tb927.7.2630 
 
GTP-binding 
protein 
 
chr. 7 
 
-2,9 
 
 2703 bp 
 
38_L_23 
 
Tb927.7.6050 
 
receptor-type 
adenylate 
cyclase 
GRESAG 4, 
putative 
 
chr. 7 
 
-3,7 
 
1 3810 bp 
 
41_B_24 
 
Tb11.57.0043 
 
variant surface 
glycoprotein 
(VSG, 
pseudogene), 
putative 
 
chr. 11 
 
-2,5 
 
 1485 bp 
 
47_F_3 
  
 
Tb927.6.2300 
 
adenosine 
kinase, putative 
 
chr. 6 
 
-3,8 
 
1  
 
53_J_12 
 
Tb927.8.5250 coatomer delta 
subunit, 
putative 
delta-COP, 
putative 
 
chr. 8 
 
-2,67 
 
  
1596 bp 
 
57_K_13 
 
Tb09.211.0960 
 
protein kinase, 
putative 
 
chr. 9 
 
-2,4 
 
 1095 bp 
 
Table 3.1 continued. 
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3.1.4.2 Microarray analysis of RNAs bound to TAP-TbRBP3: 
 
Immunoprecipitation methods have been successfully used for isolating different types of RNPs 
(ribonucleoprotein complexes) (Tenenbaum, Carson et al. 2000; Tenenbaum, Lager et al. 2002; 
Gerber, Herschlag et al. 2004; Lal, Mazan-Mamczarz et al. 2004) and in particular in our group 
the TAP-tag (Rigaut, Shevchenko et al. 1999) (Puig, Caspary et al. 2001) has allowed the 
identification of mRNAs bound to T. brucei Puf domain-proteins. (Luu, Brems et al. 2006). As 
an alternative to identify mRNAs bound to TbRBP3, I used the BS cell line containing the C-
terminal TAP-tagged RBP3. Total cell extracts of BS cells over-expressing TAP-RBP3 were 
used to purify the ribonucleoprotein complexes by binding to IgG sepharose. The RBP3-RNPs 
were recovered after digestion with TEV (tobacco etch virus) protease. The samples were then 
treated with proteinase K and total RNA was phenol-chloroform extracted and processed as 
describe above.  
The cDNA obtained was applied to the genomic microarrays (Diehl, Diehl et al. 2002; Brems, 
Guilbride et al. 2005). As a control we used samples from cells expressing the TAP-tag alone. 
Six microarray hybridisations for three independent RBP3 affinity isolations were performed. 
To prevent bias caused by preferential label incorporation, the two CyDyes were swapped 
between the two types of RNA, TbRBP3-TAP and TAP alone (pHD918). 47 clones were found 
to be enriched by more than 2.5 fold in the TAP-RBP3 cells. 3 of them (2 corresponding to 
cyclin F box and another to ZFP1) were already annotated and I chose another 20, considering 
also that they were present in all the slides analysed and sent them for sequencing. These results 
are summarized in table 3.2.  
 
 
 spot identity location characteristics Array levels RT-PCR 
7_M_23 +6.32  
47_E_14 
Tb927.5.810 
 
Chr 5 Hypothtical protein,  Zinc finger C-x8-C-x5-C-
x3-H type (and similar) +4.67  
28_E_3 +4.49 
54_J_21 
3’UTR of 
Tb927.6.3490 
Chr 6 TbZFP1 (Zinc finger protein) 
+2.96 
  
21_K_21 +10.90  
22_C_22 +4.13  
30_A_19 
3’UTR of 
Tb927.4.1000 
Chr 4 Hypothetical protein with an endoplasmic 
reticulum targeting sequence 
+6.73  
21_O_5 Tb927.1.4600  
 
Chr 1 Hypothetical protein with a Cyclin F box 
domain 
+6.07  
46_E_19 +4.54 
36_A_12 
Tb927.1.4620 Chr 1 Hypothetcal transmembrane protein 
+3.81 
 
19_F_12 Tb927.1.4630  Chr 1 Hypothetical protein with a Cyclin F box 
domain 
+5.84 
 
 
32_O_4 +3.68 
16_L_6 
Tb927.1.4650 Chr 1 Hypothetical protein with a Cyclin F box 
domain +4.93 
 
20_P_20 Tb927.1.4580 Chr 1 Hypothetical protein with a Cyclin F box 
domain 
+6.15   
8_N_6 Tb09.244.2400 Chr 9 BARP (bloodstream stage alanine-rich protein) +3.80  
14_B_21 3’UTR and ORF 
Tb927.4.1010 
 
Chr 4 Hypothetical protein (signal anchor). Orphan 
sequence. 
+4.03  
16_N_18 Tb10.70.2120 Chr 10 Hypothetical protein (signal anchor). +3.25  
17_A_4 3’UTR of 
Tb11.01.6380 
Chr 11 hypothetical protein with PSP1 C-terminal 
conserved region  
+5.67  
17_B_16 +6.32  
38_C_5 
Tb927.8.7820 Chr 8 hypothetical protein, conserved weakly similar 
to Cold shock protein. +7.20 
 
 
24_F_12 Tb927.6.1780 Chr 6 mitogen-activated protein kinase,  +3.54 
 
 
32_L_10 Tb11.03.0570 Chr 11 5’ end of CDS, including 5’UTR, and RBP3 
 3’UTR? 
+3.99  
Table 3.2. Positive clones for TAP-TbRBP3 overexpression. 
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Comparison of the previously described microarray data (from cells over-expressing or 
knocking-down RBP3) with the data obtained for the transcripts that specifically co-purify 
with the over expressed TbRBP3 showed several differences. First, in most of the cases (65%) 
at least 2 clones represented the same transcript showing the high integrity of the DNA-chips. 
Transcripts corresponding to proteins containing either a zinc finger- or a cyclin F-box 
domain were overrepresented (9 clones). An enrichment for a transcript derived from the 
same cluster as the cyclin F box domain proteins was also observed.   
In order to confirm some of these data, RT-PCR was performed. Briefly, total RNA from 
TbRBP3- and 918- flow-throughs and from the eluates after TEV cleavage were extracted and 
reverse transcribed using oligo-dT. 1:10 serial dilutions (until 1:10000) of the cDNA 
generated were used as a template for the PCR, using specific primers for each transcript. 
After 30 amplification cycles, 10 μl of each sample were run on an agarose gel.  Tubulin was 
used as a control. Figure 3.1.9 (upper part) shows an example of the microarray results for the 
2 transcripts tested and the PCR products obtained (lower part left).  As expected, a product of 
315 bp for cyclin F-box (Tb927.1.4580) and a band of 309 bp for ZFP1 (Tb927.6.3490) were 
obtained. Both products were detected at higher dilutions of template cDNA in the eluate 
from TbRBP3-TAP compared to the control. This indicates that these transcripts really bind 
this protein preferentially and therefore co-purify with the TAP-tagged TbRBP3. The results 
of the PCRs for the flow through confirmed this – the products were seen at higher dilutions 
of template in the fraction corresponding to the control.  Tubulin (380 bp) was equally present 
in the different samples. It was decided to look at the spots corresponding to these transcripts 
on the slides for the over-expressed TbRBP3 in the previous arrays. The transcripts containing 
a cyclin F-box domain were between 1.5- and 2-fold up-regulated, but this increment was not 
consistent in all the slides analysed, probably this is why they were eliminated as targets by 
the M-CHiPS analysis. Northern blot analysis of the over-expressing cell line confirmed that 
the increment of cyclin F-box mRNA was not more than 2-fold; the same was true for ZFP1 
(figure 3.9.C). 
Two other RNAs encoding for zinc finger-containing proteins were enriched in the RBP3 
eluate:  Tb927.05.810 and Tb07.11L3.90 (Figure 3.9.1.C). The latter one is a protein 
interaction partner of 14-3-3 proteins in T. brucei (C. Benz, manuscript in preparation) and it 
was found in this microarray analysis. The binding of this transcript to TAP-TbRBP3 was 
established by RT-PCR (Figure 3.1.9.B). Interestingly, the mRNA levels of both transcripts 
were 3-fold up-regulated in bloodstream forms upon over-expression of TbRBP3 (Figure 
3.1.9.C).  
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Fig. 3.1.9 Cyclin F box and ZFP mRNAs are enriched in the eluate of TbRBP3-TAP. A. Microarray 
slides showing positive spots. B. RT-PCR from eluates and flow-throughs after the first step of TAP 
purification. C.  Northern blot showing mRNA levels of  cyclin F box and ZFP after TbRBP3 over-
expression. 
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3.1.5 Interacting partners of TbRBP3 
It is well established that the role of many RRM-containing proteins is not only mediated by the 
direct interaction with RNA molecules but also with other proteins. In particular, the interaction 
of TcRBP3 with other polypeptides is known (De Gaudenzi, D'Orso et al. 2003).  To determine 
if this holds true for TbRBP3, the tandem affinity purification (TAP) procedure was used (Puig, 
Caspary et al. 2001).  As explained before, a tetracycline inducible C-terminal TAP-RBP3 was 
generated by cloning the TbRBP3 ORF into pHD918. For the TAP- purification extracts from 
cell lines over expressing the tagged protein were used and the presence of putative targets was 
detected by SDS-PAGE and silver staining. Unfortunately, it was not possible to identify 
interacting partners of TbRBP3 using this strategy. TbRBP3 itself was also not detected. It is 
possible that the protein is expressed at very low levels and therefore higher amounts of cells 
are required for the analysis. Other strategies such as immunoprecipitation using the in situ V5-
RBP3 or the myc-tagged cell line should be considered. 
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3.2 Functional characterisation of the amino acid transporter 11 3’-
UTR 
 
As mentioned in the introduction, trypanosomatids mainly regulate gene expression through 
post-transcriptional mechanisms. In particular, sequences located in the 3’-untranslated 
regions (3’-UTRs) of the mRNAs are necessary to control mRNA levels of developmentally 
regulated genes.  By microarray analysis of differentially transcribed genes in the bloodstream 
and procyclic stages of the parasite, a clone corresponding to the amino acid transporter 11 
(Tb927.4.4730) was found to be 4.8 fold up-regulated in procyclic TREU/927 cells. The main 
aim of this work was to investigate whether the 3’-UTR of the mRNA is involved in this 
developmental regulation and to find the sequences involved in this control. 
 
3.2.1 Identification of the Amino Acid Transporter (AATP) 11 3’-UTR  
To map the 3’-UTR of this amino acid transporter (AATP 3’-UTR), a reverse transcriptase 
reaction was performed with RNA from both bloodstream and procyclic T. brucei (Hug, Hotz 
et al. 1994). Oligonucleotide cz 1948 (5'-(dT)18(AGCT)3-3') was used for cDNA synthesis 
followed by a PCR using CZ 1948 and the coding sequence (CDS)-specific primer cz 1951, 
which anneals 160 nt downstream of the AATP stop codon. 1/10 volume of the PCR was used 
as a template to perform a second PCR with oligonucleotides cz1948 and cz 1952, an 
intergenic region (IGR)-specific primer that anneals to the first 24 nucleotides after the AATP 
stop codon. Several products between 0.2 and 0.8 kb were amplified, cloned into pGEM-T, 
and sequenced. Figure 3.2.1 shows the location of the oligonucleotides used (A) and the PCR 
products generated in the second PCR (B). Although it is a developmentally regulated gene 
(C), amplification products of a similar intensity were obtained from cDNAs from BS and PC.  
Sequencing analysis revealed the presence of different polyadenylation sites: at nucleotides 
64, 220 and 833, the last one was one of the most prominent bands shown in the PCR. To 
determine which one is used by the parasite, they were compared to the length of the AATP 
mature RNA. As can be seen in figure 3.1.1 C, the endogenous transcript has a size of 2.3 kb 
as estimated by Northern blot analysis: 1.4 kb corresponds to the CDS and 60 bp to the 5’-
UTR. That means that the 3’-UTR has a length of approximately 0.8 kb. Therefore the higher 
product (833 nt) obtained in the PCR must signal the polyadenylation site that is used by the 
parasite. The shorter products obtained could be due to internal priming of the oligo dT on 
poly (A) sequences within the 3’UTR of the mature RNA. 
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Fig. 3.2.1 Determination of the AATP 11 3’-UTR. A. Part of coding sequence (CDS in italics) and intergenic 
region (IGR) sequence of AATTER 11 (Tb927.4.4730). The primers used for the PCRs (CZ1951 and CZ1952) are 
shadowed. Poly pyrimidine (poly(Y)) tract is underlined and the putative polyadenylation sites obtained by PCR 
are labelled with black arrows. The polyadenylation site for the AATTER 11 mRNA is labelled with a red arrow. 
B. Products obtained during the second round of PCR (oligos CZ1952 and CZ1948). The bands were cut and 
sequenced. The higher product (0.8 kb) corresponds to the 3’-UTR. C. Northern blot showing that this amino acid 
transporter is 8 fold upregulated in procyclic cells. 
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The results obtained agree with the mechanism that has been proposed to define a 3’-UTR in 
Trypanosoma, i.e. the polyadenylation site is roughly 100 nt upstream of a polypyrimidine 
(poly(Y)) tract (8-25 nt.) which signals trans splicing of the downstream mRNA (Hug, Hotz 
et al. 1994; Benz, Nilsson et al. 2005).  The AG trans splicing acceptor, the poly(Y) tract and 
the polyadenylation sites are depicted in figure 3.2.1. 
  
3.2.2 Role of the AATP 3’-UTR in developmental regulation of a reporter gene 
To determine whether this untranslated region is involved in developmental control of gene 
expression, the 3’-UTR was amplified using the primers cz1952 and cz1948 and cloned 
downstream of the chloramphenicol acetyl transferase (CAT) reporter gene into the plasmid 
pHD1437 to generate the plasmid pHD1470. The plasmid pHD1437 is an optimised vector 
for analysis of 3'-UTRs: it contains a promoter for bacteriophage T7 polymerase to allow high 
levels of transcription (50 fold higher than RNA pol I) mediated by T7 polymerase, the 5’-
UTR of the EP1 gene and the CAT gene that allows to measure the effect of the 3-UTR in an 
easy way.  The main features of the vector are indicated in figure 3.2.2. 
 
 
 
 
Fig. 3.2.2 Backbone plasmid used for analysis of AATP 3’-UTR 
 
Both bloodstream and procyclic 427 1313/514 cell lines constitutively expressing the 
bacteriophage T7 polymerase (from pHD 514, G418 resistance) and the Tn10 Tet-repressor 
(pHD1313 phleomycin resistance) were transfected with this plasmid. After selection with 
puromycin, the effect of the 3’-UTR on CAT mRNA levels was evaluated by Northern blot 
using CAT ORF as a probe. As a control the vector containing actin 3’-UTR instead of AATP 
3’-UTR was used. Figure 3.2.3 shows the presence of a developmental regulated transcript of 
1.8 kb corresponding to CAT- AATP 3’-UTR. It is approximately 7-fold more abundant in PC 
compared to BS (35% vs. 7%), while the levels of the reporter mRNA under the control of 
actin 3’-UTR were the same in both life stages. This difference is consistent with the values 
obtained for the endogenous AATP transcript. To measure the effect at the translational level, 
CAT assays of cellular extracts were performed. CAT activity in procyclic cells was 9.5-fold 
higher than in bloodstreams, reflecting the regulation observed at the mRNA level and 
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indicating that this regulatory element is also involved in translational control, although at low 
level. Therefore the AATP 3’-UTR is involved in developmental control of gene expression. 
 
 
 
 
 
 
 
 
To study in more detail which sequences are involved in this regulation, several deletion 
mutants were created. In order to choose the regions to be deleted, the secondary structure of 
the 3’-UTR was predicted using M-FOLD, on the server Rensselaer Polytechnic Institute's 
School of Science (www.bioinfo.rpi.edu/applications/mfold/rna/form1.cgi) using the default 
values as parameters. The most probable structure considering the plot energy was chosen and 
3 big deletions were done: 1 (the first 39 nt and the last 113 nt were deleted, 631 remained), 
2 (between 142 and 257 nt, 718 remained) and 3 (between 290 and 618, 505 bp) generating 
the plasmids pHD1481, pHD1482 and pHD1483 respectively (Figure 3.2.4). 
 
 
Fig. 3.2.3 AATP 3’-UTR is involved in developmental regulation of CAT. A. CAT mRNA levels from PC and BS 
under the control of AATTER-3’-UTR and actin 3’-UTR. B. CAT activity of the cell lines tested (cpm/ug protein). 
CAT-Actin 3’-UTR was used as positive control. 
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Fig. 3.2.4 A sequence contained in the Deletion 3 plasmid is involved in developmental control of CAT. A. 
Secondary structure of the AATP 3’-UTR. Regions selected for the deletions are shown. B. CAT activity (left 
chart) and mRNA levels (right column) expressed as percentage of actin (100%). C. Northern blot of the different 
mutants. 
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After transfection and selection with puromycin, total RNA was extracted and Northern blots 
were done. The CAT activity of the protein extracts was also measured. The values shown in 
figure 3.2.4 (Northern blot is shown in C and the values obtained are shown at the right side 
of the chart) are expressed as a percentage of CAT-actin 3’-UTR. For deletion 1, a transcript 
of about 1.5 kb in size was obtained, while for the other 2 deletions 2 different transcripts 
were detected: one of the expected size (1.7 and 1.2 kb for deletion 2 and 3 respectively) and 
another one 400 bp smaller, indicating the use of an alternative polyadenylation site.  In 
procyclic cells, CAT mRNA levels were slightly down-regulated in the 3 constructs 
generated, but this reduction was less than 50% compared to the plasmid containing the entire 
3’-UTR. In bloodstream forms, the mRNA levels decreased to 50% for the first deletion while 
for deletion 3, the amount of transcript was 2-fold higher compared to the whole 3’-UTR 
(pHD1470). However, these differences were not highly significant. 
CAT assays were done to check the effect of the three deletions at the translational level 
(figure 3.2.4 part B). In contrast to what was observed with mRNA abundance, CAT activity 
increased for 1 and 3 in procyclic cells, resulting in an activity that was between 20-25% 
higher as that obtained for pHD1470.  In bloodstream forms, the difference in CAT activity 
was only significant for deletion 3. For this construct, the CAT activity increased 7-fold 
compared to the entire 3’-UTR, which equals 90% of the value obtained for the whole AATP 
3’-UTR in procyclics and indicates that there is a destabilising sequence between nt 290-618 
that down-regulates gene expression at both transcript and translational levels in bloodstream 
forms.  
To map in more detail this destabilising region, 4 smaller deletions (of 50 nt in average) 
encompassing structural elements in this region were done, generating plasmids pHD1575 
(4, 290-350 nt), pHD1576 (5, 380-420 nt), pHD1577 (6, 535-610 nt) and pHD1578 (7, 
448-500 nt). Drastic changes in CAT mRNA levels were however not observed. The effect at 
the translational level was more evident in procyclic cells (Figure 3.2.5). In particular, for the 
cells containing deletions 4 and 6 the levels of CAT activity increased by almost 3-fold 
compared to the cell line carrying the whole 3’-UTR and they were 20% higher than the actin 
3’-UTR (positive control), suggesting the presence of elements that are normally inhibiting 
translation.  In bloodstream cell lines, the protein activity was not considerably affected; only 
for deletion 4 a 4-fold increase in CAT activity was observed. However, it does not reach the 
levels previously observed for the large deletion in these cells.  Therefore a smaller regulatory 
sequence could not be defined. Considering that the regions to be deleted were based on a 
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prediction, the possibility that the regulatory element was not included in the mutants cannot 
be entirely ruled out. 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.5 Smaller deletions in region 3 affected translational activities. A. Secondary structure of deletion 3 and the 
regions chosen to be deleted. B. CAT activity and mRNA levels. 
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3.2.3 Looking for proteins involved in control of AATP 3’-UTR 
 
3.2.3.1 Electrophoresis mobility shift assay (EMSA) 
The effect obtained with deletion 3 indicated the presence of regulatory sequences in this 
region, so we decided to look for proteins that interact with this part of the 3’-UTR and 
therefore mediate this effect. The first approach was to check for direct protein:RNA 
interactions using electrophoresis mobility shift assay (EMSA). This technique is central to 
study gene regulation and is based on the observation that sequence-dependent protein:DNA 
or protein:RNA complexes migrate more slowly than free nucleic acid molecules when 
subjected to non-denaturing polyacrylamide or agarose gel electrophoresis. Because the rate 
of DNA migration is shifted or retarded upon protein binding, the assay is also referred to as a 
gel shift or gel retardation assay.  
For the assay, first the region corresponding to the nucleotides 290-618 was amplified by 
PCR and cloned into pBlueScript SK as HindIII/BamHI. This allows in vitro transcription of 
the fragment using either T7 or T3 polymerase, generating either a sense or an antisense 
probe, the latter being used as a negative control. The in vitro transcription was done using 
Maxi Script II (Ambion) using 
32
P-UTP, and the labelled probe purified. 10000 cpm of each 
transcript (sense and antisense) were incubated with 30 μg of cellular extracts from either 427 
1313/514 procyclic or bloodstream forms in the presence of tRNA as a competitor for 15 min 
at 25°C. Then the samples were run on a non-denaturing 6% polyacrylamide gel, dried and 
exposed to a film at -70°C overnight.  In the first attempts to this assay the probes were 
degraded during the incubation time, so we decided to select the nucleic acid binding proteins 
present in the extracts through heparin-sepharose chromatography. Using this approach a 
small band with slower migration was observed using the sense probe and procyclic extracts 
(Figure 3.2.6), however later attempts to reproduce and improve the results were 
unsuccessful.  
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3.2.3.2 Tobramycin affinity chromatography 
As a second approach to identify trans elements interacting with the AATP 3’-UTR, I used an 
RNA affinity tag developed to isolate pre-mRNA-spliceosome complexes. It has previously 
been shown that a 40 mer aptamer stem-loop (named J6f1) stochiometrically binds the 
aminoglycoside antibiotic tobramycin under physiological conditions. The dissociation 
constant is approximately 5 nM and it can strongly discriminate between similar 
aminoglycosides with respect to binding (for G-418 Kd is 5 μM). The sequence for the 
aptamer was generated using the partially overlapping primers cz2436 and cz2437, amplified 
by PCR and introduced between the CAT gene and the 3’-UTR BamHI of pHD1470 
generating the plasmid pHD1644. This plasmid was used to transfect bloodstream and 
procyclic 427 1313/514 cells. A diagram of the purification procedure is depicted in figure 
3.2.7. Briefly, cell extracts from cells containing and lacking the antibiotic binding site are 
incubated with a previously coupled tobramycin-derivatised Sepharose beads. After several 
washing steps, proteins bound to the 3’-UTR coupled to the RNA-aptamer molecule can be 
eluted by adding an excess of this aminoglycoside. 
Fig. 3.2.6 EMSA to detect interacting 
partners of TbRBP3. Cell extracts from 
both BS and PC were incubated with an in 
vitro transcribed deletion 3 (sense) and run 
into a non denaturing PAGE 5%gel. 
Degradation of the free probe is observed.  
A small band with slower migration is seen 
in PC incubated with the sense probe. 
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After transfection, the presence of the aptamer-reporter mRNA was monitored by Northern 
blot and the ability of the transcript to bind to the tobramycin matrix assessed. For this, total 
RNA from cells containing and lacking the aptamer was extracted and incubated with the 
derivatized matrix. After elution, the RNA was reverse transcribed and the cDNA obtained 
used as a template for PCR. Unfortunately no product was observed (data not shown), 
suggesting that the RNA did not bind to the antibiotic. One possible explanation is that the 
stem loop structure is hidden and therefore not accessible to the beads. For this reason another 
approach was followed. 
 
3.2.3.3 Pull down of RNP complexes using tethered-based systems 
The tethered function analysis has been employed to test the function of many RNA binding 
proteins (Coller and Wickens 2002). It consists of an RNA:protein interaction that is mediated 
by a chimeric protein containing a peptide which binds a specific RNA stem loop with high 
affinity and a reporter mRNA carrying  the  recognition sites. I tried to adapt the system to 
pull down the proteins bound to the AATP 3’-UTR and the overall concept is summarized in 
figure 3.2.8. For this purpose several cell lines were generated that constitutively express the 
reporter containing the tether RNA between the CAT reporter gene and the 3’-UTR. Then 
these parasites were cotransfected with a plasmid containing a tetracycline inducible tethererd 
protein (figure 3.2.8 upper part). After induction by adding tetracycline, the tethered protein 
will interact with the tether RNA bound to specific interacting proteins (lower part). These 
mRNPs can be isolated by immunoprecipitation. The success of the procedure can be assessed 
Fig. 3.2.7 A. Diagram of the aptamer based-affinity 
chromatography to purify RNP complexes. B. Northern blot 
showing the transcript for CAT-AATP 3’-UTR (1470) and the 
reporter with the aptamer (1470+Aptamer). Other constructs 
containing this loop are shown: PGKs 3’-UTR (1442) and actin 
3’-UTR (1462). 
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by Western blot to detect the tethered protein and the specificity of the bound mRNA can be 
evaluated using RT-PCR. Most important, the interacting partner of the 3’-UTR can be 
identified by mass spectrometry. The constructs used for this approach are listed in table 3.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                              
 
System Plasmids Features Cloning sites 
pHD 1644 pHD 1470 (AATP 3’-UTR) + aptamer Jf61 
(Cho, Hamasaki et al. 1998; Hartmuth, Urlaub et al. 
2002)         
Tobramycin 
affinity 
pHD 1668 pHD 1462 (Actin 3’-UTR) + aptamer Jf61 
(Cho, Hamasaki et al. 1998; Hartmuth, Urlaub et al. 
2002) 
BamHI 
 
 
MS2 tethered based 
pHD 1706 pHD1470 (AATP 3’-UTR)  + 2 MS2 
binding sites (from pIII-MS2-4) (SenGupta, 
Zhang et al. 1996).  
BamHI 
pHD 1709 pHD 918 + MS2 CP  (DNA template from 
S. cerevisiae 140ura3pHybLex/Zeo-MS2) 
(invitrogen) (SenGupta, Zhang et al. 1996))              
                
HindIII/BamHI 
pHD 1710 pHD1709 + 1 myc tag (from pHD1484).       
 
pHD 1711 pHD1709 + 2 myc tags (from pHD 1700).    
NsiI/HindIII 
-N peptide tethered based 
pHD 1708   pHD 1470 (aatter 3’-UTR) + 5 Box B sites   BamHI 
pHD 1693            pHD1502 (pHD924+ N)+ EGFP          HindIII/HpaI 
 
pHD 1704 pHD1502  (pHD 924 +N)  + GST         HindIII/HpaI 
 
   
pHD 1743 pHD918+ -N +EGFP+TAP              -N: 
HindIII/ApaI 
EGFP: 
ApaI/HpaI 
TAP:HpaI/Bam
HI 
Fig. 3.2.8 Schematic representation of the tethering strategy to pull down AATP-3’-UTR RNP 
complexes. The RNA recognition site and the tethered proteins used are shown. 
Table 3.3 Systems and plasmids used to purify RNP AATP 3’-UTR RNP complexes 
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3.2.3.3.1 MS2 coat protein system:  
The first system employed was derived from the coat protein of the coliphage MS2 (MS2 
CP), an RNA-binding protein of low molecular weight (13 kDa) involved in translational 
repression by binding to a 33 nt RNA secondary structure (MS2 loop) within the translational 
initiation region of the coliphage replicase gene (Peabody and Ely 1992; Peabody 1993). The 
interaction between these elements is cooperative, so adding more MS2 hairpin loops 
increases the affinity.  Two MS2 binding sites were inserted between the CAT gene and the 
AATP 3’-UTR from pHD1470. The new construct was transfected into 427 1313/514 
procyclic cells and selected by adding puromycin.  A tetracycline inducible 2 myc-MS2 CP 
fusion protein was generated and used to co transfect procyclic cells carrying pHD1706 and 
selected with hygromycin. The expression of the protein was induced by addition of 
tetracycline (100 ng/ml). As a control I used a cell line containing the plasmid pHD1470 
(without the RNA binding site) and the MS2 CP. The CAT-MS2-AATP 3’-UTR RNPs were 
pulled down by immunoprecipitation with anti-myc sepharose and eluted from the beads by 
adding myc-peptide. In order to standardize the conditions I performed an IP from 35S-
methionine metabolic labelled cell extracts. The myc-MS2 CP was detected as 17 kDa band in 
the eluates of both cell lines (Figure 3.2.9), suggesting that the IP parameters were accurate. 
This was also confirmed by Western blot. However, later attempts to precipitate the RNP 
complexes failed because the cell line lost the expression of the fusion protein during culture, 
and even initially it was produced at low levels. 
 
 
 
 
Fig. 3.2.9 Anti-myc antibody is able to immunoprecipitate MS2 CP. A. Immunoprecipitation with 35S 
metabolically labelled procyclic cells containing either the reporter gene without binding sites or the protein 
alone or the over expressed protein and the reporter gene with MS2 binding sites. B. Western blot of procyclic 
cells expressing MS2 CP with 1 or 2 myc-tags and after immunoprecipitation Anti-myc antibody was used. 
Amount of cells: upper part: 1x106 cells. For the immunoprecipitation 1x106 cells were used and 7x106 cells.  
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3.2.3.3.2 -N peptide systems: 
Due to the low expression of the MS2 CP, an alternative strategy consisting of a  N-peptide 
was followed. This molecule is derived from the N protein of the lambda bacteriophage and it 
is involved in the antitermination mechanism of transcription of early genes through the 
interaction with the box B in the nascent RNA (Chattopadhyay, Garcia-Mena et al. 1995, 
Barik, 1987 #112). This is a 15 nt RNA stem loop frequently used for tether analysis (Coller 
and Wickens 2002).  The approach is analogous to that described for MS2. Briefly, 5 copies 
of the box B were inserted in the reporter plasmid. Procyclic cells containing the new 
construct were cotransfected with several tetracycline inducible proteins containing the -N 
peptide. Three different fusion proteins were tested:  EGFP- (pHD1693), GST- (pH1704) 
and -EGFP-TAP (pHD1743).  Cell lines carrying the protein and the reporter construct 
without the RNA binding sites were used as negative controls. 
The first system employed consisted of the EGFP- protein. The presence of the GFP had the 
advantage of allowing easy detection of protein expression by immunofluorescence and 
available anti-GFP antibodies.  The anti--N peptide antibody was not used in any of the 
systems tested because of its low specificity and poor availability. The expression of the 
fusion protein was assessed by Western blot (Figure 3.2.10 B, upper panel). As expected, a 
band of 26 kDa is recognized by anti-GFP antibodies after induction of the protein in 
procyclic forms. A cell line containing EGFP alone was used as a control 
Immunoprecipitation of metabolically labelled cell extracts using anti-GFP antibody showed 
that the tagged protein was efficiently pulled down, and no signal was observed in the 
supernatant (Figure 3.2.10 A). After scaling up the system (to 3x108 cells) the protein could 
not be immunoprecipitated as efficiently as before and most of it was found in the supernatant 
but not in the eluate. This is shown in the lower part of figure 3.2.10 B (see third line in both 
supernatant and eluate fractions). The specificity of pull down of CAT--AATP 3’-UTR 
mRNA was evaluated by RT-PCR after IP using a forward oligonucleotide that anneals to the 
CAT  coding sequence and a reverse primer annealing to the 3’-UTR, and primers for actin 
and cyclin F box as controls. PCR analysis of the RNA present in the supernatant is shown in 
part C of the figure 3.2.10. Only signals for actin and cyclin F box were detected in the 
control (reporter without Box B).  No PCR product was obtained when the PCR was done for 
detecting CAT-AATP 3’-UTR, although the construct is present in the cells. This result was 
not expected, as most of the RNA must be present in the supernatant fraction of the IP. It is 
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assumed that the RNA was degraded either during the IP or the purification step. It might also 
be that the interaction between the mRNA and the proteins is weak and easily disrupted 
during the procedure.  
 
 
 
 
 
 
 
 
In order to stabilise the interaction between the components of this RNP, a reversible 
chemical cross linking step using formaldehyde was performed.  Briefly, procyclic forms over 
expressing EFGP- N peptide were incubated with 1% formaldehyde for 10 min to allow the 
formation of the cross-link and the IP was performed as usual. After the elution step, the 
crosslink was reversed by incubating the samples at 70 degrees for 45 min.  Unfortunately no 
PCR products were obtained suggesting that the binding was not improved by this 
preliminary step (data not shown). 
 
Fig. 3.2.10 Immunoprecipitation using EGFP-  as tethered protein. A. Immunoprecipitation tith 35S 
metabolically labelled procyclic cells containing either the reporter gene without binding sites or the protein 
alone or the over expressed protein and the reporter gene with box B. B. upper panel: Western blot of procyclic 
cells expressing EGFP alone and with the tagged version. An increase of 2 kb is seen in the band recognized by 
anti GFP. Lower panel: Western blot after IP with Anti-GFP antibody. First line: PC with the reporter gene 
(without box B). Second line: PC containing EGFP. Third line: PC containing the reporter-B Box construct and 
over expressing EGFP-. C. To check the binding specificity RT-PCR was done. No amplification products 
were obtained. 
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The last approach followed was to construct a fusion protein containing the  N-peptide at the 
N terminus followed by EGFP and a TAP tag at the C terminus (pHD1743). The general idea 
was to pull down the RNA reporter and the interacting proteins using the  N-peptide and 
then to purify the complexes performing the first step of the TAP purification, as explained 
before. The Western blot in figure 3.2.11 shows a procyclic cellular extract before and after 
induction of the protein by adding tetracycline. A band of 45 kDa is recognized by antibodies 
against the 3 different components of the construct.  
 
 
 
Then a TAP purification using the accurate negative control, procyclic cells carrying the 
plasmid for the protein (pHD1743) and the reporter without the binding sites (1470) was 
done. Western blot analysis using anti-GFP antibody indicated that the purification was 
successful (Figure 3.2.12 lower part).  RT-PCR was performed to check the binding 
specificity of the reporter to the protein. However a band of similar intensity was obtained in 
both eluates (test and negative control), suggesting that CAT-AATTER 3’-UTR was 
unspecifically sticking to the beads (Figure 3.2.12 upper part). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.11 over expression of    N- EGFP –
TAP in procyclic cells. The protein was over 
expressed after addition of tetracycline (+). 
Antibodies against the different “tags” were used:   
anti- N peptide (left), anti-GFP (middle) and 
PAP (right)O 
Fig. 3.2.12 Unspecific RNAs are 
pulled down during -EGFP-TAP 
purification. A. RT-PCR from total, 
supernatant and eluate RNA 
obtained after TAP purification of 
PC containing the CAT reporter 
construct with (AATP + Box B) or 
without box B (AATP) as a negative 
control. B. Western blot of (2x106 
cells) the different fractions using 
anti-GFP antibody. After the 
cleavage by TEV protease the -
EGFP segment is release in the 
eluate. 
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To reduce the unspecific interactions of other transcripts with the IgG-sepharose column, 
tRNA from yeast was used as RNA competitor. For this, IgG sepharose beads were 
preincubated for 2 hours with 100 μg/mL tRNA. However, this approach was not useful. The 
RNA from the control cell line (without the box B) was present in the elution fraction at 
similar levels to the reporter construct containing the specific binding sites (Figure 3.2.13 A).  
As a second alternative, heparin was included during the incubation of the extracts with the 
IgG beads. Two different heparin concentrations were tested: 0.5 and 1 mg/ml. In both 
situations PCR products for CAT-box B-AATP3’-UTR were obtained. However, PCR 
products were also obtained with the negative control (CAT-AATP 3’-UTR) indicating that 
the presence of heparin did not reduce unspecific binding of RNA to the beads. Figure 3.2.13 
shows the PCR products obtained from eluates using 1 mg/ml heparin. In summary, several 
attempts to precipitate the RNPs interacting with the AATP-3’-UTR under “physiological” 
conditions were unsuccessful because the reporter mRNA was not bound with sufficient 
specificity to the IgG sepharose. An alternative method might be the coupling of in vitro 
transcribed reporter mRNA to an affinity column and subsequent incubation with cellular 
extracts. Although this is a totally artificial situation, this approach should be considered. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.13 Unspecific binding of AATP 3’-UTR. PCR from RNAs after TAP purification using 
tRNA as a RNA competitor (A) or heparin 1 mg/ml (B). Oligos CZ2232 and CZ2089 were used to 
amplify the 3’-UTR in A and in B CZ2232 and CZ2090 were used. In both cases the reporter RNA 
without the box-B element was pulled down. 
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3.3 Determination of CAT toxicity mediated by PGKC 3’-UTR in 
Trypanosoma brucei bloodstream forms 
 
These results were published ((Colasante, Robles et al. 2007)).   This is a summary of the 
work I did (see supplementary material.) 
 
The PGK (phosphoglycerate kinase) cluster is the best studied model for polycistronic 
transcription in Trypanosoma brucei. It consists of 3 genes and 2 of them – PGKB and PGKC 
are developmentally regulated. PGKC is present in the glycosomes of bloodstream cells and 
its mRNA steady state levels are 20-fold higher than in procyclic cells. On the other hand, 
PGKB is located in the cytosol of insect cells and its mRNA levels are 10-fold upregulated. 
Previous studies done in the lab demonstrated that the 3’-UTR of these transcripts is involved 
in this regulation.  In this work, Claudia Colasante went further into the mechanism of 
regulation of PGKC in BS using the same approach that I used for the characterisation of the 
AATP 3’-UTR: a CAT reporter gene under the control of the PGKC 3’-UTR.  
While identifying the regulatory sequences of this 3’-UTR, an interesting fact was observed: 
it was not possible to get transfectants of BS with the CAT reporter construct containing the 
whole PGKC 3’-UTR when the transcription was driven by RNA T7 polymerase (a strong 
promoter) while they were easily obtained when a weak promoter (endogenous RNApol II) 
was used. The difficulty in obtaining bloodstream trypanosomes expressing high levels of 
CATPGKC mRNA suggested that either the RNA or the protein might be toxic. I tried to 
determine which of these assumptions was true (see Figures 5 and 6 A of this manuscript). 
For this, a reporter plasmid containing a tetracycline-inducible promoter was made. The 
plasmid (“j” (pHD 1667) in Figure 5A), was transfected into trypanosomes BS and CAT 
mRNA and enzyme activity were measured. The clones obtained did not show any phenotype 
in the absence of tetracycline (Figure 5B), but upon addition of the antibiotic, cell growth was 
impaired (Figure 5B). An increase in CAT activity and in CAT-PGK mRNA was observed 
after the induction (Figure 5C). Using a specific probe for PGKC 3’-UTR it was possible to 
establish that the CAT-PGK mRNA levels were ten-fold higher than that of the endogenous 
PGK mRNA (Figure 5C) and that the PGKC mRNA endogenous levels were unaffected by 
the CAT induction. CAT-PGKC mRNA levels were higher than the control (CAT-Actin 3’-
UTR mRNA). Overall these results suggest that an excess of CAT is toxic for the cells. At the 
same time, I was able to get one cell line containing the constitutively expressed reporter 
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construct. Although this clone grew slowly, it was possible to perform CAT assays and 
Northern blots (Figure 5 C). 
To determine whether the toxicity was due to CAT protein or CAT-PGK mRNA, translation 
initiation was inhibited by inserting a (G)30 sequence upstream of the CAT gene (G-
CATPGKC) (plasmid “m” in figure 5). After transfection and selection by adding puromycin, 
the expression of G-CAT was induced by addition of tetracycline.  In contrast to the data 
obtained before, no phenotypic effect was observed in these cells and CAT activity also 
decreased, suggesting that an excess of CAT protein was causing the toxicity. Unfortunately, 
CAT mRNA levels also decreased (even lower than the control).  Therefore it was not 
possible to determine the cause of this toxicity. 
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4 Discussion 
 
4.1 TbRBP3 
RRM-type proteins belong to the most abundant class of RNA binding proteins in eukaryotes. 
They are required to control many aspects of RNA metabolism, from RNA synthesis of the 
nascent chain to its degradation.  In Trypanosomatids, these proteins are involved not only in 
universal processes such as transcription and translation but also in very specialized events 
that are characteristic of this genus such as trans splicing and RNA editing of mitochondrial 
transcripts.  Due to the unusual organisation of the genome, these parasites exclusively rely on 
post-transcriptional mechanisms to control gene expression (e.g., splicing, mRNA 
degradation and translation), and although the molecular bases of them have been elucidated, 
not much is known about the regulatory elements involved in developmentally regulated gene 
expression control. Therefore the search and characterisation of these proteins are required to 
gain a better and deeper understanding of the parasite.  
As most of the RRM-type proteins, TbRBP3 is a modular protein (Figure 3.1). The only 
region with high homology between the different RBP3s found in other species of 
Trypanosomatids and related proteins is the RRM-motif, in particular the RNP-1 motif, with a 
predicted secondary structure . TcUBP1 also contains a glutamine-rich region at the 
C terminal domain present in an   helical conformation that might be involved in protein-
protein interactions.  
Two facts led us to believe that TbRBP3 has a regulatory function in development in this 
parasite: both over-expression and RNAi knockdown of TbRBP3 transcript in bloodstream 
forms considerably impaired the cell growth (Figures 3.1.4 and 3.1.5.) while the insect form 
was not affected. Although the depletion of the mature transcript was not complete (30% of 
the endogenous mRNA still remained after 24 hours in both life cycle stages), and therefore 
some amount of the protein is still present, this down-regulation was enough to observe a 
phenotypic effect. Considering that the most related proteins to RBP3 are involved in the 
control of mRNA steady state levels in T. cruzi (De Gaudenzi, D'Orso et al. 2003) and in T. 
brucei (C. Hartmann, manuscript in preparation), TbRBP3 could be also implicated in a 
similar mechanism.  To determine whether mRNAs were specifically up- or down-regulated 
in bloodstream forms with altered RBP3 levels, microarray analysis was performed (Diehl, 
Diehl et al. 2002; Brems, Guilbride et al. 2005). Although several transcripts were observed to 
be differentially regulated in these analyses (table 3.1), these results could not be confirmed 
by Northern blot analysis. This was unexpected as the Northern blot is more sensitive, and it 
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has been found that the observed changes in regulation are higher than the reported ones for 
microarrays (C. Benz, C. Hartmann, D. Luu, personal communication), so higher differences 
would have been expected. So far there is no good explanation for this inconsistency, apart 
from the fact that RBP3 might not be involved in the control of mRNA levels.  
The interaction of members of the TcRBP family with different T. cruzi transcripts has been 
reported in in vitro RNA binding assays as well as in vivo by co-immunoprecipitation from 
RNP complexes. TcUBP1 specifically interacts with Tcsmug, tssa, cruzipain and amastin 
transcripts, while Tcsmug mRNA is bound to TcUBP2 in vivo (De Gaudenzi, D'Orso et al. 
2003). In order to identify endogenous mRNAs associated with TbRBP3 in bloodstream 
forms, a combination of affinity purification of TAP tagged TbRBP3 and microarray analysis 
of RNAs associated with the mRNP complexes was used. Although the main purpose of the 
tandem affinity purification is to identify interacting proteins under native conditions, it has 
also been used to identify ligands (nucleic acids, lipids, peptides) that interact, directly or 
indirectly, with the target protein (Rigaut, Shevchenko et al. 1999; Puig, Caspary et al. 2001; 
Gerber, Herschlag et al. 2004). Preliminary results showed that five of the clones of the 
microarray analysis that copurify with TAP-RBP3 coded for proteins containing the cyclin F 
box domain, while another four were related to two zinc finger proteins.  RT-PCR analysis 
confirmed the selective binding of one of the transcripts for each protein family (Figure 
3.1.9).  
Proteins containing cyclin F box domains play roles in very diverse cellular processes, such as 
polyubiquitination, transcription elongation, centromere binding and translational repression. 
Usually these proteins contain other associated motifs such as WD- and leucine-rich repeats 
that are also involved in the binding of the protein to its substrates (Kipreos and Pagano 
2000). In T. brucei, the cyclin F box transcript is developmentally regulated, and about 2-fold 
more abundant in bloodstream forms. The role of these proteins in Trypanosomatids is under 
study (C. Benz, C. Hartmann, manuscript in preparation).  
The recent completion of the T. brucei genome predicts the presence of 65 proteins containing 
zinc finger domains of the C-x8-C-x5-C-x3-H type (CCCH) many of them carrying further 
accessory domains. This type of proteins is characterised by its ability to interact with RNA 
and thereby affecting mRNA stability and localisation. In T. brucei, a group composed of 
three small CCCH zinc finger proteins has been involved in differentiation from bloodstream- 
to procyclic forms. TbZFP1 is downregulated in bloodstreams and an enrichment in TbZFP1 
levels after initiation of differentiation to the procyclic form has been observed (Hendriks, 
Robinson et al. 2001; Hendriks and Matthews 2005). Two of the clones enriched in the pull 
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down experiments of TAP-TbRBP3-RNPs followed by microarray analysis contained the 
TbZFP1 3’-UTR. Although this does not mean that the interaction of the protein with this 
mRNA is mediated by the untranslated region, it would not be surprising considering that the 
interaction of most of the RNA binding proteins that are involved in gene expression control 
is mediated through this region of the mature RNA. In this sense, it could be that TbRBP3 is 
involved in the post-transcriptional regulation of TbZFP1. One possibility is that the 
interaction of the protein with TbZFP1 transcripts in bloodstream forms might affect the 
stability of the mature transcript promoting its degradation. However, the data obtained from 
the microarray analysis of both the over-expressed- and knocked down- cells lines contradict 
this hypothesis. This might be due to the fact that the filtering conditions selected were too 
high so that several putative targets were undetectable. And in fact, the levels of these 
transcripts (Cyclin F box domain-containing proteins and ZFP1) were not considerably 
affected in the former microarray analysis. In the case of cyclin F box, the transcript was not 
more than 2-fold upregulated when TbRBP3 was over-expressed and TbZFP1 was almost not 
affected. Northern blots from total RNAs showed that the difference was no more than 2-fold 
upregulation in both cases (3.1.9.C). This suggests that although TbRBP3 interacts with the 
transcripts, it is not involved in the control of their steady state levels.  
TbRBP3 might also be involved in translational repression of TbZFP1 at this stage. In this 
sense, tethered function analysis might be useful to elucidate the role of this protein. It was 
not determined whether the role of TbRBP3 in post-transcriptional control of TbZFP1 is 
reflected in the differentiation process as monomorphic (that is differentiation incompetent) 
cell lines are commonly used for this kind of studies.  
Interestingly, two other transcripts encoding proteins containing a single ZFP domain were 
pulled down with TbRBP3-TAP (table 3.2 and figure 3.1.9). One of them was found in this 
study. The other one, Tb07.11L390, was previously found as an interacting partner from 
14.3.3 proteins by TAP purification (C. Benz). Tb07.11L390 mRNA levels were also 3-fold 
upregulated by the over-expression of TbRBP3 in bloodstream forms (figure 3.1.9). Since 
many transcripts containing ZFP domains seem to interact with RBP3, it is tempting to 
consider a general role of this protein in their regulation. Autoregulation mediated at the level 
of mRNA stability has been reported for transcripts encoding RRM-type proteins as 
AUF1/hnRNPD (Zhang, Wagner et al. 1993; Wilson, Sun et al. 1999; Banihashemi, Wilson et 
al. 2006) and for the zinc finger CCCH-type tristetraprolin (Brooks, Connolly et al. 2004), 
through AU-rich elements present in the 3’-UTR. However, a similar mechanism between 
different kinds of RNA binding proteins has not been observed, and it is difficult to assess the 
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functional significance of such an interaction. Forty seven clones of the genomic microarray 
showed enrichment in the binding to the protein, 23 of them were already sequenced and the 
binding of two of them was confirmed by RT-PCR. RT-PCRs still have to be done to confirm 
the interaction of the other transcripts. The identity of the other 24 clones remains to be 
determined.  
TcRBP3, the homologue in T. cruzi, is a cytosolic protein only present in the epimastigote 
stages (De Gaudenzi, D'Orso et al. 2003). Using two different tagged versions of TbRBP3 it 
was possible to establish that the protein is located in the cytoplasm of both procyclic and 
bloodstream forms and concentrated in the perinuclear space. In order to rule out any 
mislocalisation due to over-expression of the tagged protein, in situ tagging of the protein was 
also done. This allowed confirmation of the results obtained above, and it was also an indirect 
way to establish that unlike to what was found for the T. cruzi homologue, the protein is 
constitutively expressed in African trypanosomes.   
RRM-type proteins can also establish protein-protein interactions either to recognise the RNA 
target or to mediate RNA-independent functions. For instance, the heterodimeric splicing 
factor U2snRNP auxiliary factor (U2AF), binds to SF1 through its RRM binding domain 
called UHF during the initial stages of pre-mRNA splicing in S. cerevisiae (Rain, Rafi et al. 
1998; Kielkopf, Lucke et al. 2004). Although this kind of modification has not been observed 
in Trypanosoma, protein-protein interactions can be mediated through accessory domains. In 
T. brucei, TSRP1 binds to TSR and U2AF35 during trans splicing (Ismaili, Perez-Morga et 
al. 2000), and TcUBP1 and TcUBP2 bind to the poly(A) binding protein (PABP) to regulate 
the stability of Tcsmug and amastin transcripts in a stage specific manner  (De Gaudenzi, 
D'Orso et al. 2003). Considering the results obtained from the TAP-TbRBP3 microarray 
analysis, it would be interesting to determine whether this protein does not only interact with 
cyclin F-box- and ZFP-containing transcripts but also with the polypeptides. I looked for 
TbRBP3 binding partners by using the tandem affinity purification (TAP) approach in 
bloodstream forms. The main advantage of this method is that it allows the purification of the 
protein under native conditions and the identification of protein complexes in stoichiometric 
amounts without previous knowledge of the complex composition, activity, or function 
(Rigaut, Shevchenko et al. 1999; Puig, Caspary et al. 2001). However, this approach has 
failed to identify TbRBP3 interacting partners. It is possible that the protein levels of the 
targets are low, that they were not observed in the silver stained-SDS PAGE gel or that the 
presence of the TAP tag disrupts the putative interactions, as it has been reported that 
sometimes the addition of the C-terminal tag to a protein can impair its function (Puig, 
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Caspary et al. 2001). Another possibility would be that the protein-protein interactions are 
only transient or too weak and therefore not detectable with this method.  
 
These results indicate that TbRBP3 might have more than one function in regulation in T. 
brucei. At the posttranscriptional level, this protein is involved in the regulation of specific 
mRNA levels in this parasite. The fact that alterations in its abundance affect cell growth 
underlines its importance. TbRBP3 might also be required to control other mechanisms 
involved in RNA homeostasis and the effect of RBP3 on translation should be investigated 
further. 
 
4.2 Functional analysis of AATP 11 3’-UTR 
One of the most interesting aspects of Trypanosomatids when compared to other eukaryotes is 
their control of gene expression: due to the lack of polymerase II promoters in these 
organisms and polycistronic transcription they cannot regulate this process at the classical 
level of transcription initiation. Therefore gene expression control is mainly mediated at post-
transcriptional levels through pre-mRNA processing i.e., trans-splicing and polyadenylation, 
mRNA stability and translation. All of them require the presence of sequences located in the 
3´-UTRs that recruit protein complexes in a precise moment when it is necessary for the cell. 
In this work I identified regulatory elements present in the amino acid transporter 11 (AATP) 
3´-UTR. These elements are involved in the differential expression of this transcript during 
the Trypanosoma life cycle, and might provide information to get a deeper insight into the 
developmental control of gene expression in Trypanosoma brucei. 
In bloodstream trypanosomes, glycolysis is the major source of ATP (Michels, Hannaert et al. 
2000). In contrast, in the procyclic form, which grows in the Tsetse fly, the mitochondrial 
metabolism is more important than glycolysis (van Weelden, van Hellemond et al. 2005). In 
the insect, the parasite uses amino acids, mainly proline to generate energy. Therefore the 
amino acid transporters (AATP) are expressed in this life stage, as it has been demonstrated 
for T. cruzi and Leishmania (Akerman, Shaked-Mishan et al. 2004; Bouvier, Silber et al. 
2004; Canepa, Silber et al. 2004; Geraldo, Silber et al. 2005).  As an indicative of this, the 
steady state level of the endogenous AATP 11 transcript is 8-fold higher in procyclic than in 
bloodstream forms (Figure 3.2.1); it is not known whether this difference is maintained at the 
protein level.  The experimentally determined 3´-UTR fits to the in silico predicted one, 
which was generated by an algorithm that uses several distinct parameters to predict 
processing sites of mature mRNA transcripts (Benz, Nilsson et al. 2005).  
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The first impression if we consider just the sequence of this untranslated region is that this 
region might be involved in destabilization of the mature transcript. Three different kinds of 
destabilising elements are present in this 3’-UTR: five AU-rich elements type I (AUUUA) 
spread along the whole 3’-UTR, several U-rich sequences and one copy of the core motif of 
the 26-mer element of EP procyclin transcripts. In higher eukaryotes, AU-rich elements are 
involved in destabilising short-life transcripts such as oncogenes and interleukins and also in 
inhibiting or promoting translation (Barreau, Paillard et al. 2005). The presence of the 26-mer 
core element (UAUUUUUU at the RNA level) is not surprising. It is known that this element 
is significantly overrepresented among the 3’-UTRs of developmentally regulated genes, 
being present in the 3’-UTR of one-third of procyclic form enriched transcripts (like PGKB 
and COX) and 8% of 3´-UTRs for bloodstream-enriched transcripts (Hotz, Lorenz et al. 1995; 
Clayton and Hotz 1996; Hotz, Biebinger et al. 1998; Irmer and Clayton 2001; Mayho, Fenn et 
al. 2006). The fact that these sequences are found in the 3'-UTR suggested that AATP 11 
expression could be regulated at the mRNA stability level, the translational level, or both 
(Zhang, Kruys et al. 2002).  The predicted secondary structure of the AATR 3`-UTR (figure 
3.2.4) showed that apart from 3 U-rich regions predicted to adopt a single stranded 
conformation,  most of these elements were interacting with other nucleotides, and therefore 
might not be functional.  
As has been observed for many developmentally regulated genes in Trypanosoma, the 3’-
untranslated region is responsible for the differential expression of the AATP mRNA in insect 
forms. The mRNA levels of the reporter construct CAT-AATP 3`-UTR were 5-fold 
upregulated in procyclic forms compared to bloodstream forms. Although these values did not 
fully reflect the regulation level of the endogenous mRNA, they are very similar to those 
obtained for the endogenous transcript (8-fold). An artefact due to over-expression conditions 
cannot be discarded. Moreover, this region is also under a slight translational control as CAT 
activity was 10-fold higher in the insect forms.  
There are several steps at which mRNA abundance can be regulated: at the stage of mRNA 
processing, export from the nucleus and degradation. For instance, there is a 5- to 10- fold 
increase in transcription initiation and in transcription elongation of the EP procyclin genes in 
procyclic compared to bloodstreams forms (Furger, Schurch et al. 1997). As it was explained 
before, regulation of mRNA stability is the major way of controlling mRNA amounts in 
Trypanosoma. EP and PGKB mRNAs have half-lives of about 5 min in bloodstream forms 
and over an hour in procyclic forms (Hotz, Hartmann et al. 1997; Haile, Estevez et al. 2003). 
Preliminary results (data not shown) indicate that the same is true for the endogenous AATP 
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mRNA:  the transcript is unstable in bloodstream cells (after addition of Actinomycin D the 
half life is less than 10 min compared to more than 1 hour in procyclic cells). Half life 
measurements of the reporter constructs have to be done to determine whether this model 
reflects the regulation of the endogenous mRNA. If the half-life of the CAT-AATR 3’-UTR 
mRNA is different from the value obtained with the AATR 11 transcript, it could be reflected 
in the steady state levels of the transcript. It is known that transcript abundance is determined 
by RNA stability (Clayton 2002). 
Deletion of the main domains of the secondary structure of the AATP 3’-UTR allowed the 
identification of a regulatory element located between nt 290-618. In bloodstream forms this 
deletion (3) causes a 2.2-fold increase in the CAT-3 AATP mRNA levels and a 7-fold 
upregulation in CAT activity.  This represents 90% of the CAT activity observed in insect 
forms containing CAT-AATP 3`-UTR. This region contains two of the U-rich tracts that are 
predicted to be present in single stranded conformation. The results shown for the deletions 
were not consistent with those obtained with the reporter containing the whole 3’-UTR. 
Apparently, translational control plays a more important role in regulating the expression of 
the reporter gene.  It could be that the regions deleted are too big, so that other regulatory 
elements are masking the effect at the mRNA level. It has been reported that the secondary 
structure of mRNA 3’-ends is critical in determining their effects on mRNA abundance (Hotz, 
Hartmann et al. 1997; Irmer and Clayton 2001). Although the predicted models of the 
secondary structure for the different deletions indicate that the overall structure was 
maintained, an alteration in the secondary structure of the 3’-UTR cannot be ruled out. If the 
folding of the 3’-UTR is affected, it might also be reflected in the mRNA levels obtained for 
CAT-3 AATP. Half life measurements would be useful to establish if the stability of this 
reporter construct increases in bloodstream forms.  
Attempts to delimitate the region involved in the control were unsuccessful as the mRNA 
levels were slightly lower than the values obtained for the CAT-AATP 3’-UTR transcript in 
both procyclic and bloodstream forms (Figure 3.2.5). However, it was possible to identify two 
regions involved in translational repression which are not required for differential expression 
at the transcript level in both life stages: between 290-350 nt, (CAT-4 ATTP) and between 
535-610 nt, (CAT-6 ATTP). Both constructs showed enzymatic activities higher than the 
CAT-actin control in procyclics, whereas in bloodstream forms only the CAT-4 ATTP 
activity was elevated. However, it did not reach the values obtained with CAT-3 ATTP 
(35% vs 49%). Looking for special motifs in these regions, 6 bears the U-rich element plus 
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one AU-rich element type I partially present as a single strand AUUUA. It is unlikely that this 
motif is functional, so the translational effect might be mediated by the U-rich element.  
Translational repression is involved in the regulation of many AU-rich containing mRNAs in 
eukaryotes. Using in vitro translation studies it has been determined that these sequences 
inhibit the stable association of the small ribosomal subunit with the TNF mRNA (Wax, 
Nakamura et al. 2005) through their interaction with TIA-1(Piecyk, Wax et al. 2000). In T. 
brucei, the 26-mer polypyrimidine tract is required to down-regulate the few EP procyclin 
mRNA transcripts that are still produced in bloodstream forms (Hotz, Hartmann et al. 1997). 
Although the mechanism of degradation of this transcript has been well established (Li, Irmer 
et al. 2006), it is not known how the translational control is achieved. It might be that the 
translational repression observed for CAT-AATR and EP procyclin is similar to the control of 
the cytokine mentioned before. Interestingly, in mammalian cells, the increased expression of 
the cationic amino acid transporter (Cat-1) during amino acid deprivation is due to increased 
mRNA levels and enhanced translation mediated by the interaction of the RNA binding 
protein HuR with AU-rich elements located in the 3’-UTR (Aulak, Liu et al. 1996; Hyatt, 
Aulak et al. 1997; Aulak, Mishra et al. 1999; Yaman, Fernandez et al. 2002). 
 
Since it was not possible to delimitate the region in 3 involved in the developmental 
regulation of CAT-AATR 3’-UTR mRNA it was considered that perhaps the whole region 
and/or a structure only formed when the entire region is present, is required to exert this 
control.  
  
4.2.1 Does over-expression of CAT-AATP and CAT-PGKC transcripts affect 
gene expression control? 
The best studied model of developmentally regulated genes in trypanosomes whose 
transcription is driven by pol II is the phosphoglycerate kinase (PGK) gene cluster. The 
developmental regulation is mediated by a poor trans splicing signal in the case of PGKA 
(Kapotas and Bellofatto 1993) and by the 3’-UTR for PGKB and PGKC (Blattner and Clayton 
1995). There are approximately 20 molecules of PGKC mRNA in one bloodstream form cell, 
0.006% of the total mRNA molecules present. At the translational level, there is a 50-fold 
upregulation: the parasite contains 300,000 molecules of PGKC protein, 0.35% of the total 
protein molecules in the cell (Jurgen Haanstra data, unpublished). If there were the same 
amount of AATP mRNA molecules as for PGKC transcript in procyclic cells (20 molecules), 
these would correspond to 0.003% of the total mRNA molecules. We do not have data about 
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the regulation at the protein level, but if the CAT-AATP reporter gene reflects the behaviour 
of the endogenous gene, 6,000 molecules of AATP 11 protein should be present in one insect 
form cell. The transcription of the CAT-AATP and CAT-PGKC construct is driven by T7 
polymerase, which increases the amount of primary transcript about 20-fold, so it would be 
400 mRNA molecules of either CAT-AATR or CAT-PGKC per cell and 120,000 protein 
molecules of CAT-AATR and 6x105 protein molecules of CAT-PGKC. The excess of CAT 
under the control of PGKC 3’-UTR in comparison to the protein produced with the AATR 3’-
UTR construct was reflected in the difficulty to get a bloodstream cell line containing the 
CAT-PGKC reporter construct when the transcription was driven by a constitutive T7 
polymerase promoter. This was only possible after inserting a tetracycline operator region in 
order to make the transcription tetracycline inducible.  Moreover, the growth of these cells 
was impaired after induction of the reporter (Figure 5). It was not possible to determine 
whether this toxicity was either due to an excess of CAT mRNA or of CAT protein. We did a 
reporter construct containing a G30 track between the 5’-UTR and CAT ORF to inhibit 
translation initiation. Unexpectedly, the CAT-G30-PGKC mRNA levels were decreased as 
well as the CAT activity. The secondary effects seen using the strong T7 promoter were 
overcome when the transcription was mediated by polymerase I promoter (Colasante, Robles 
et al. 2007). If the mRNA turnover of AATP and PGKC were mediated by a regulatory protein 
which is involved in stabilisation of the transcripts in either procyclic or bloodstream cells by 
interacting with the 3’-UTR and this factor is present in limiting amounts, then it might not be 
enough protein to bind to the 3’-UTR of the over-expressed reporter and the endogenous 
transcript, and this might be reflected in the destabilisation of the mRNA and also in the 
mRNA steady state levels. CAT-PGKC mRNA half life was shorter when the transcription 
was driven by T7 polymerase than when driven by polymerase II (Colasante, Robles et al. 
2007). However, it is not clear if this effect was mediated by the promoter itself or by an 
excess of RNA molecules.  
 
4.2.2 Looking for a protein involved in the developmental regulation of AATP 11 
We wanted to identify factors responsible for targeting the –AATP mRNA either for 
degradation and/or for translational repression. RNA stability and translation modulation 
usually involves the interaction of sequences in the 3’-UTR with regulatory proteins (as was 
described above) which recruits the degradation machinery (exosome and 5’ to 3’ 
exonucleases) or affects translation.  
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To date, no more than 10 AU-rich binding proteins (AUBP) with an established function in 
mRNA turnover and translation have been described in mammals and they are involved in the 
control of 5-8% of the total mRNA transcripts in humans (Bakheet, Williams et al. 2006). 
Most of them have different properties and only share their affinity to AU-rich elements and 
their role in mRNA turnover and/or translation   (Lai, Stumpo et al. 1990; Zhang, Wagner et 
al. 1993; Aulak, Liu et al. 1996; Min, Turck et al. 1997; Carballo, Lai et al. 1998; Wilson and 
Brewer 1999; Chen, Gherzi et al. 2001; Stoecklin, Colombi et al. 2002). These properties 
were later found to be important for ARE-binding by mobility shift assays (using either the 
purified epitope tagged version of the protein or cytosolic extracts from AUBP 
overexpressing cells) and mRNA half life measurements of reporter genes (Zhang, Wagner et 
al. 1993; Aulak, Liu et al. 1996; Carballo, Lai et al. 1998; Wilson and Brewer 1999). So far 
none of these regulators has been identified through direct interaction with its target mRNA. 
There are two of these proteins in Trypanosoma: the ARE-binding proteins TcUBP1 and 
TcUBP2 in T. cruzi. TbUBP1 and TbUBP2 in T. brucei are involved in stabilisation of a 
transcript encoding a protein containing a cyclin F box domain (C. Hartmann, manuscript in 
preparation). The T. cruzi proteins were found by searching ESTs and Genome Sequence 
Surveys for clones having homologies with eukaryotic ARE binding proteins such as 
members of the ELAV family (D'Orso and Frasch 2001; D'Orso and Frasch 2002) and then by 
homology, TbUBP1 and TbUBP2 could be identified (C. Hartmann manuscript in 
preparation).   
The interaction of TcUBP1 with AU rich sequences present in the 3’-UTR of Tcsmug 
transcripts in epimastigotes of T. cruzi (D'Orso and Frasch 2001) and the interaction of the 
mammalian HuR with  U-rich elements in the 3’-UTR of PGKB, EP1 and PPDK  has been 
established by electrophoretic mobility shift assay (EMSA) (Quijada, Guerra-Giraldez et al. 
2002). In these examples the binding between the RNA probe and the protein was already 
suspected and purified protein was used in the reactions. I tried to adapt the technique using 
the region encompassing the 340 nt of the AATR 3 3’-UTR and total cell extracts of either 
procyclic or bloodstream forms.  After selection of nucleic acid binding proteins by heparin-
Sepharose chromatography, a weak-retarded migrating band was observed in extracts from 
the insect form (figure 3.2.6). However, attempts to reproduce the interaction failed. It is 
recommended to use RNA probes of less than 100 nt in length to minimize unspecific binding 
and to have good resolution during the running in the non-denaturing gel. However, this 
approach was used by (Coughlin, Teixeira et al. 2000) to detect a 36 kDa protein in cellular 
extracts from Leishmania amastigotes, using the in vitro transcribed amastin 3’-UTR, that has 
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a size of 700 nt as a probe (Coughlin, Teixeira et al. 2000).  It might be that the complex 
between 3-AATR RNA and the putative protein was too big to be resolved on a 4% PAGE 
non denaturing gel.  
 
4.2.2.1 Attempts to identify regulatory factors under native conditions 
One of the main disadvantages of shift binding assays is that they do not reflect physiological 
conditions. An ideal way to overcome this problem is to isolate the ribonucleoprotein (RNP) 
particles under native conditions. Aptamers selected against nucleic-acid binding proteins and 
small molecular-weight ligands have been used to investigate protein and nucleic-acid 
sequence specificity. Isolation of pre-splicesosome associated proteins, like U1 and U2 
snRNP were done using an in vitro transcribed pre-mRNA containing an RNA aptamer which 
has high affinity to tobramycin (Hartmuth, Urlaub et al. 2002; Hartmuth, Vornlocher et al. 
2004). I used this protocol to isolate CAT-AATP 3’-UTR RNP complexes under native 
conditions.  Preliminary assays to demonstrate the binding of the reporter transcript bearing 
the J6f1 aptamer to the tobramycin derivatized Sepharose failed. Although M-FOLD analysis 
of the J6f1-AATP 3´-UTR indicated that the secondary structure was maintained, it is 
possible that the folding of CAT-aptamer-AATP 3’-UTR impaired the access of the affinity 
site to the tobramycin matrix. It is important to indicate that the studies done so far include the 
binding site either at the 3’-end (Hartmuth, Urlaub et al. 2002; Hartmuth, Vornlocher et al. 
2004) or the 5’-end (Vazquez-Pianzola, Urlaub et al. 2005), and that in vitro transcribed RNA 
coupled to the tobramycin matrix was used, which means that only one RNA species is 
present in the assay.  
TcUBP1 is expressed in the three different cell stages of the parasite and selectively binds 
transcripts in each stage.  Its role in mRNA turnover is dual, either increasing mRNA 
stabilisation or promoting mRNA degradation, similar to AUF1 in mammalian cells. This 
suggests that TcUBP1 could act in the formation of different RNP complexes in different 
developmental stages. In epimastigote stages, it interacts with PAB1 and TcUBP2 to stabilise 
TCSMUG transcript.  TcUBP1 also binds TSSA mRNA in epimastigotes and destabilises the 
transcript. TcUBP1 and TcPABP1 bind amastin mRNA in both epimastigotes and 
trypomastigotes. The presence of few proteins involved in regulation of several transcripts 
might also be the case for T. brucei and probably they are part of different RNP complexes, in 
some cases interacting with an mRNA in a particular stage while in other situations 
recognising mRNAs in more than one parasite stage. If this were the case, the amount of 
protein would be a limiting factor in regulating the expression of CAT-AATR and CAT-PGKC 
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mRNAs. It might also be possible that the protein is part of another RNP complex involved in 
the regulation of other genes, and therefore not present in sufficient amounts to regulate all 
the over-expressed CAT-AATP transcripts. 
Tethered function analysis approaches using AUBPs have been performed to determine their 
function in mRNA turnover. The roles of CUG-BP1 (CELF1) (Barreau, Watrin et al. 2006), 
TTP, BRF1 (Lykke-Andersen and Wagner 2005) and KSRP (Chou, Mulky et al. 2006) as 
stimulators of degradation and /or promoters of translation were assessed using fusion 
proteins containing the MS2 coat protein. Modifications of this assay, in which the tethering 
protein is used as a tag for mRNAs have been used to determine the cellular localisation of 
several transcripts (Coller and Wickens 2002; Kedersha, Stoecklin et al. 2005; Liu, Valencia-
Sanchez et al. 2005; Sheth and Parker 2006). Recently, this methodology was adapted to 
isolate RNPs. By using a -GST affinity chromatography it was possible to isolate and 
identify 40LoVe, a protein involved in the localisation of VGL mRNA in Xenopus oocytes 
(Czaplinski, Kocher et al. 2005). I used two different tethering systems as a tag to identify 
associated proteins: an N-myc tagged version of MS2 coat protein and GFP bearing the -N 
peptide at the C terminus. Both systems were successful in immunoprecipitating the tethered 
protein as shown by western blot using anti-myc or anti-GFP antibodies, respectively.  
However, the low expression of the myc-tagged MS2 coat protein was a clear disadvantage to 
pull down proteins associated with the AATP-3’-UTR. On the other hand, the 
immunoprecipitation using the GFP- tethered protein was inefficient, as most of the tethered 
protein was found in the supernatant (Figure 3.2.9).  It was not possible to detect any 
transcript in the supernatant of the -GFP by RT-PCR either, indicating that the RNA was 
degraded either during the immunoprecipitation or the RNA extraction, even in the presence 
of RNase inhibitors during the procedure. We decided to change the reporter and included a 
TAP tag segment at the C-terminal domain, which allows efficient recovery (about 80%) of 
the protein and also has other advantages as mentioned above (Rigaut, Shevchenko et al. 
1999; Puig, Caspary et al. 2001), generating a -N peptide-EGFP-TAP fusion protein. Instead 
of purifying the RNPs by classical immunoprecipitation, the complexes were pulled down 
during the first step of the TAP purification and eluted by TEV protease cleavage. 
By RT-PCR we detected the control transcript in the pulled down fraction (CAT-AATTP 3’-
UTR) as well as the reporter bearing the B-boxes. Unfortunately, it was not possible to 
eliminate the non-specific binding of the transcript control to the protein using different 
competitors (tRNA and heparin sulphate) (Figure 3.2.13).  
 
Discussion 
 99
Using metabolic labeling followed by TAP purification it was not possible to detect any 
protein specifically bound to the reporter containing the B-boxes (data not shown). 
Considering that the putative regulatory element binds to the 3’-UTR in the reporter construct 
but not to the tethering protein, this interaction might be disrupted during the TAP 
purification. In vivo cross-linking (chemical or UV-mediated) might be useful to stabilise 
these interactions. Moreover, although both the reporter transcript and the tagged protein are 
over-expressed in the cells, the amount of regulatory protein is the same, and the protein 
background that unspecifically interacts with any domain of the protein is high, making the 
detection by SDS-PAGE difficult. It can also not be ruled out that this polypeptide was part of 
a different RNP by the time the protein extracts were prepared. Therefore a higher amount of 
cells might be required to identify proteins bound to the AATP 3’-UTR.  
Other methodologies to find RNPs have been also established, they include the rescue of 
mutants that are unable to degrade an unstable reporter mRNA (BRF1) (Stoecklin, Colombi et 
al. 2002) and the introduction of a modified nucleotide (biotin-dT) at a defined site into a 
synthetic oligoribonucleotide, protein-RNA cross-linking, isolation via the RNA-bound biotin 
and purification in high yield for analysis by mass spectrometry. However, many steps are 
required for this approach, the RNA must be produced with three modifications, that is, a 
position-specific cross-linker, a neighboring biotin, and a radioactive label, and the specific 
site for the binding of the protein needs to be intact in order to do the cross-link. Moreover, 
the amount of cross-linked product must be obtainable in a quantity sufficiently large to be 
analyzed by MS (Rhode, Hartmuth et al. 2003) 
As an alternative, it is possible to do the assay under in vitro conditions, using an in vitro 
transcribed reporter gene coupled to the tether protein as an affinity ligand and cytosolic 
extracts from which interacting proteins can be pulled down. Although it is not the ideal 
solution, it might be useful to find proteins which are involved in the targeting of 
developmentally regulated transcripts to the degradation machinery and the translational 
apparatus of the cell.  Another possibility is to do a complete TAP-tag purification and to look 
by mass spectrometry for associated complexes. 
 
The identification of the elements involved in developmental regulation of the AATP in T. 
brucei confirms the relevance of the sequences located in the 3’-UTR in post-transcriptional 
regulation. Although the identification of trans acting factors involved in this control remains 
unsolved, their identification would be helpful to clarify the preliminary steps of 
developmentally regulated mRNA turnover.  
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5 General abbreviations 
 
aa  amino acid 
Amp  ampicillin 
APS  ammonium persulfate 
ARE               AU-rich element 
ATP  adenosine-5-triosephosphate 
AATR            amino acid transporter 
bs  bloodstream form 
bp  base pairs 
BSA  Bovine Serum Albumin 
bsd  blasticidin 
CAT  chloramphenicol acetyl transferase 
CIP                 calf intestinal phosphatase 
COX               cyclooxigenase 
CP                   coat protein 
cpm                 counts per minute 
DAPI  4’, 6’-diamidino-2-phenylindole 
dATP  2’-deoxyadenosine 5’-triphosphate 
dCTP  2’-deoxycytidine 5’-triphosphate 
DEPC  diethyl pyrocarbonate 
dGTP  2’-deoxyguanosine 5’-triphosphate 
DNA  deoxyribonucleic acid 
dNTP  deoxyribonucleoside triphosphates 
dsRNA double-stranded RNA 
DTT  1,4-Dithiothreitol 
dTTP  2’-deoxythymidine 5’-triphosphate 
E. coli  Escherichia coli 
EDTA             ethylenedinitrilo tetraacetic acid 
EMSA             electrophoresis mobility shift assay 
et al.  and others 
ESAG  expression site associated gene 
FCS  fetal calf serum 
fig.  figure 
HAT               human African trypanosomiais 
HOT               head over tail 
Hyg                 hyrgomycin 
IPTG               isopropyl--D-thiogalactopyranoside 
KAc                potassium acetate 
kb  kilobase 
kD  kilo Dalton 
kDNA  kinetoplast DNA 
LB  Luria-Bertani 
MOPS  3-(N-morpholino) propane sulfonic acid 
mRNA messenger RNA 
mRNP  messenger ribonucleoprotein 
neo  neomycin 
nt  nucleotide 
OD  optical density 
ORF  open reading frame 
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PABP              poly(A) binding protein 
PAGE  polyacrylamide gel electrophoresis 
PBS   phosphate-buffered saline 
pBS  plasmid Bluescript 
pc  procyclic 
PCR  polymerase chain reaction 
PGKB(C)        phosphoglycerate kinase B (C) 
pH  -log [H+] 
phleo  phleomycin 
pI  isoelectric point 
RBP  RNA binding protein 
RNA  ribonucleic acid 
RNAi  RNA interference 
RNA pol RNA polymerase 
RNase  ribonuclease 
rpm  rounds per minute 
RRM  RNA recognition motif 
rRNA  ribosomal RNA 
RT  room temperature 
SDS  sodium dodecyl sulfate 
SL  spliced leader 
SSC  saline sodium citrate 
spp  subspecies 
TAE  Tris-acetate-EDTA 
TAP  tandem affinity purification 
TCA  tricarboxylic acid 
TE  Tris-EDTA 
TEMED N,N,N’,N’-tetramethylethylenediamide 
tet  tetracycline 
Tris  tris(hydroxymethyl)aminomethane 
tRNA  transfer RNA 
Tcsmug           Trypanosoma cruzi small mucin gene 
Tssa                Trypanosoma cruzi small surface molecule 
U, u  unit 
UBP               U-rich binding protein 
URE               U-rich element 
UTR  untranslated region 
UV  ultraviolet 
Vol  volume 
VSG  various surface glycoprotein 
wt  wild-type 
w/v  weight/volume 
X-Gal  5-bromo-4chloro-3-indolyl--D-galactosidase 
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